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CHAPTER I 
 
INTRODUCTION 
 
The topic of this dissertation is the development of novel algorithms and 
bioinformatics tools for proteomics data analysis. This chapter provides a general 
introduction to the field of proteomics and the data analysis process. The following is not 
intended to be a complete coverage of all areas of proteomics, but rather to serve as an 
overview in order to provide an understanding of the work detailed in the following 
chapters. 
 
I.1 Mass Spectrometry-Based Proteomics 
I.1.1 Overview 
Proteomics as a discipline can be defined as the identification and quantification 
of the complete set of proteins in a cell or tissue at a particular state. Although a number 
of alternative proteomics strategies such as protein array based methods have been 
developed, mass spectrometry (MS)-based proteomics has become the method of choice 
for large-scale studies. The applications of MS-based proteomics approaches have proved 
to be successful in molecular and cellular biology research including post-translational 
modification (PTM) identification and protein-protein interactions (Aebersold & Mann 
2003). With recent improvements in instrumentation and methodology, proteomics has 
undergone tremendous advances over the past few years, enabling many powerful 
applications such as functional analysis of complex organisms (Schrimpf et al. 2009), 
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global analysis of PTM (Witze et al. 2007), large-scale reconstruction of protein 
interaction networks (Gstaiger & Aebersold 2009) and introduction of proteomics in 
clinical and translational research (Bousquet-Dubouch et al. 2011). 
 
Peptide Mixture Liquid Chromatography Electrospray Ionization Mass Spectrometry
Isolate Ions of Peptide Collide Ions to Dissociate Collect Fragments in Tandem MS
Protein Mixture Protein DigestionBiological Sample Sample Fractionation
SDS-PAGE
2D-gel 
electrophoresis
Tandem Mass Spectra Peptide Identifications Confident Peptide List Assembled Protein List
 
Figure 1. The typical MS-based proteomics workflow.  
 
The typical workflow for a bottom-up MS-based proteomics experiment is 
illustrated in Figure 1. The first step is to reduce the complexity of a biological sample by 
one or several separation techniques such as SDS-PAGE and two-dimensional (2D) gel 
electrophoresis. Large proteins are then digested to peptides using site-specific proteases. 
Next, peptide mixtures are separated by liquid chromatography and ionized in a mass 
spectrometer. Precursor ions with particular mass-to-charge (m/z) values are selected and 
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collided with nonreactive gas to generate fragment ions. The corresponding m/z values 
and peak intensities of fragment ions are recorded in tandem mass spectra, which are 
interpreted to peptides by computational tools. Finally, the identified peptides are 
assembled into a list of proteins that are most likely present in the sample. 
 
I.1.2 Sample Preparation and Separation 
In proteomics studies, complex biological samples that contain a large number of 
proteins are often separated to simple mixtures prior to MS analysis. Various separation 
techniques can be used for this purpose. A widely used approach is to separate protein 
mixtures by SDS-PAGE, and then cut the gel to fractions for MS analysis. Samples of 
high complexity are now often fractionated by 2D-gel electrophoresis (Kenrick & 
Margolis 1970), which separates proteins based on their isoelectric points and molecular 
weights. Each spot in the gel may represent one or several purified proteins that can be 
further analyzed by MS. Recently a gel-based peptide-level isoelectric focusing approach 
(Hörth et al. 2006) has been shown to provide complementary coverage to the 
conventional gel-based fractionation method and yield higher identification rates (Hubner 
et al. 2008).  
A gel-free approach known as shotgun proteomics directly analyzes large 
mixtures of peptides by coupling the electrospray ionization (ESI) of mass spectrometer 
in-line with a liquid chromatography (LC) system. Peptides are separated in the 
chromatography system to reduce the complexity. Two major types of LC systems are 
reverse phase high pressure liquid chromatography (RP-HPLC) that separates molecules 
by hydrophobicity and ion exchange chromatography that separates molecules by their 
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charges. High complexity samples can be separated using the multidimensional protein 
identification technology (MudPIT) (Washburn et al. 2001), which consists of a two 
dimensional chromatography. The first dimension is usually a strong cation exchange 
(SCX) column with high loading capacity. Eluted samples are subsequently separated by 
a reverse phase chromatography.  
An alternative approach is the use of affinity chromatography to selectively enrich 
certain types of peptides or proteins. Affinity chromatography is often used to enrich 
post-translational modified peptides or proteins to make them more measurable by mass 
spectrometers. For example, the immobilized metal ion affinity chromatography (IMAC) 
can be used to enrich phosphopeptides (Thingholm et al. 2009), and  blended antibody 
columns can be used to deplete plasma samples before MS analysis (Dayarathna et al. 
2008, Pernemalm et al. 2009), which is a very effective way to reduce the sample 
dynamic range. 
 
I.1.3 Protein Digestion 
Proteins are usually cleaved to peptides by high specificity proteases prior to MS 
analysis. Trypsin is by far the most commonly used protease that cleaves peptides at the 
C-terminal side of arginine and lysine. Most proteins have tryptic cleavage sites that 
produce peptides with proper length for MS analysis. The cleavage generates “tryptic 
peptides” if both ends of peptide sequences conform to the trypsin cleavage rules. 
Specific cleavage on only one end of peptide sequences produces “semi-tryptic peptides”. 
Sometimes the “missed cleavages” may occur if resulting peptides contain internal 
trypsin cleavage sites.  
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The trypsin cleavage leaves a basic residue at the C-terminus which allows for a 
positive charge in acidic solution, producing charged peptides for MS analysis. 
Alternative site-specific protease such as chymotrypsin, GluC, LysC and AspN may also 
used in proteomics experiments, mainly for the increase of sequence coverage to 
distinguish homologous proteins or map PTM.  
 
I.1.4 Mass Spectrometry Instruments 
A mass spectrometer consists of three components: an ionization source, a mass 
analyzer and a detector. Peptides eluted from the LC system are transformed to gas phase 
charged ions, and then separated by mass analyzers with respect to their m/z values. 
Finally, the detector records the ions passing through mass analyzers, and reports them as 
mass spectra with m/z values of detected ions on the horizontal axis and their intensities 
on the vertical axis. 
The ionization source introduces analytes into the instrument by transforming 
peptides or proteins to charged gaseous ions. Two major types of ionization methods in 
proteomics studies are matrix-assisted laser desorption/ionization (MALDI) (Tanaka et al. 
1988) and ESI (Fenn et al. 1989). MALDI method co-crystallizes analytes with a matrix 
and applies UV laser light to vaporize them to charged ions. ESI sprays analytes to small 
droplets under high voltage. These droplets are subsequently vaporized to charged ions. 
Typically ions generated from MALDI are singly charged and ESI produces both singly 
and multi-charged ions.  
The mass analyzer separates the charged ions based on their m/z values. In a 
bottom-up LC-MS/MS experiment, tandem mass spectra (MS/MS) are achieved by 
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performing two mass analyses. The first MS analysis measures the m/z values of ions 
(precursor ions), and selects ions in a certain range to undergo fragmentation. The 
selection can be controlled by instrument software. An exclusion list that contains the m/z 
values of most recently fragmented precursor ions can be used to reduce sampling 
redundancy. The resulting ions (product ions or fragment ions) are separated in the 
second mass analysis to generate tandem mass spectra.   
Common mass analyzers used in proteomics experiments include quadrupole, ion 
trap, time of flight (TOF), Fourier transform ion cyclotron resonance (FTICR) and 
orbitrap. Each instrument has its strengths and weaknesses with respect to the speed, 
mass accuracy and resolution. More detailed discussions of these instruments are 
available in recent reviews (Yates et al. 2009, Chalkley 2010). 
The ion trap instrument is probably by far the most widely used mass 
spectrometer due to its robustness, high sensitivity and relatively low price. However, the 
mass accuracy of ion trap is relatively low. In addition, there is a trade-off between the 
depth of the trapping potential and the width of the m/z range. Hence, in order to still 
contain the precursor ions, the m/z range has to be compromised. Usually ions below 1/3 
of the precursor ion m/z will not be scanned in MS/MS, which is known as “low mass 
cut-off” of ion trap. For example, a peptide with 10 amino acids may have a neutral mass 
as 1100 Da. Even it is doubly charged, the ions below 183 m/z may not be acquired. In 
contrast, the mass range of immonium ions of amino acids is from 30 to 159. Therefore, 
immonium ions are often not observed in ion trap. 
A recent major breakthrough is the proliferation of the LTQ-Orbitrap mass 
spectrometer (Hu et al. 2005). This hybrid instrument combines the robustness and 
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sensitivity of ion trap instruments with very high resolution and mass accuracy 
capabilities. It also has a higher dynamic range than FTICR (Makarov et al. 2006). In 
addition, LTQ-Orbitrap instruments can be configured to preserve low mass ions that are 
not observed in ion traps (as discussed in next section). The fast sequencing speed, high 
mass accuracy and high dynamic range make it particularly suitable for both qualitative 
and quantitative analysis of complex peptide mixtures (Olsen et al. 2009).  
The mass accuracy and resolution of mass spectrometers have a substantial effect 
on the collected spectra. High mass accuracy also enables accurate determination of 
peptide ion charge state, thus greatly benefits the subsequent data analysis. It has been 
observed that data produced from high mass accuracy instruments can be better 
interpreted by bioinformatics tools (Zubarev & Mann 2007).  
 
I.1.5 Peptide Fragmentation 
Fragmentation Methods 
In LC-MS/MS experiments, selected precursor ions are fragmented to product 
ions before detection. Figure 2 illustrates possible ions fragmented along the peptide 
backbone. The ion type depends on where peptide breaks and which side of the fragment 
receives the proton(s). If the charge is retained on the N–terminal side of the fragmented 
peptide, a, b or c ions are created, while x, y or z ions are generated if the charge is on the 
C-terminal side.  
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Figure 2. Theoretical fragmentation of a peptide. Adapted from Figure 2 in Wysocki et al. 
(2005). 
 
Collision-Induced Dissociation (CID) is currently the most commonly used 
fragmentation method. Low-energy CID that is often used in quadrupoles and ion trap 
instruments mainly generates a, b, y ions and their neutral losses of water or ammonia. 
CID is a sensitive method and works well for low charged peptides (+2 or +3). However, 
labile modifications such as phosphorylation and glycosylation often lost during CID. In 
addition, it does not fragment long peptides well. These disadvantages can be solved by 
introducing Electron Transfer Dissociation (ETD) (Coon et al. 2005). ETD produces 
sequence-independent fragmentation and generates c and z ions. It particularly works 
well for long peptides, which can be generated by using other proteases instead of trypsin. 
Although ETD has lower sensitivity than CID, it preserves the labile modifications, 
making it a valuable method for phosphorylation and glycosylation studies.  
Since CID works better for short peptides while ETD excels for long peptides, 
these two fragmentation methods therefore complement each other. A “decision-tree” 
model (Swaney et al. 2008) has been developed to assess peptide ions on-the-fly and 
determine which fragmentation method should be applied to these ions. This approach 
produced almost 40% more peptide identifications compared to CID alone.  
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Another fragmentation method is the Higher-energy Collision Dissociation (HCD) 
that is available in LTQ-Orbitrap instruments. It is particularly useful to pinpoint 
modifications such as phosphorylation because the immonium ions generated from HCD 
fragmentation will be preserved in mass spectra (Olsen et al. 2007). In addition, other low 
mass ions missing in ion trap instruments can be detected in LTQ-Orbitrap via HCD 
fragmentation, producing more abundant peaks in mass spectra. The high mass accuracy 
and abundant ions in the HCD spectra may greatly facilitate the downstream peptide 
identification (Bereman et al. 2011). 
CID fragmentation is well supported by almost all peptide identification tools, 
while software for the analysis of ETD fragmentation data is currently less developed, 
and not all identification tools are now fully optimized to handle ETD data. Recent 
efforts have been made to develop new scoring methods specifically for the analysis of 
ETD spectra (Sadygov et al. 2009, Sun et al. 2010). A study also showed that an 
optimized scoring algorithm for ETD data can dramatically increase spectral 
identifications (Baker et al. 2010). 
 
Understanding Fragmentation Pathway 
The gas-phase peptide fragmentation process has not yet been fully understood. A 
number of studies have been conducted to investigate the fragmentation pathway 
(Wysocki et al. 2000, Zhang 2004, 2005, Klammer et al. 2008). The “Mobile Proton 
Model” (Wysocki et al. 2000) describes the fragmentation pathway under low-energy 
collision. In an ion trap instrument, for example, protonated precursor ions are trapped 
and undergo precursor ion selection, fragmentation, and fragment ion detection in the 
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same space. During CID, an ion trap applies a “tickle” RF voltage to induce peptide 
fragmentation. Under this voltage, precursor ions are excited to a higher internal energy 
level by collisions with nonreactive gas, making the charged proton migrating to 
energetically less favored protonation sites, such as peptide backbone. With a proton at 
the carbonyl oxygen of an amide bond, the preceding carbonyl can serve as a nucleophile 
to attack this carbonyl oxygen, forming an intermediate ring structure that subsequently 
breaks to dissociate the peptide bond (see Figure 3). The N-terminal fragment forms a b 
ion and C-terminal fragment becomes a y ion. This “charge directed” fragmentation 
occurs simultaneously in many molecules of the same peptide, resulting in different b and 
y ions that can be detected in MS/MS scan. 
 
NH2
R3
O
NH
R4
O
OH
NH2
O
NH
R2
OH+
NH2
R3
O
NH
R1
R4
O
OH
NH2
O R2
O
R1 NH
+
+
 
 
Figure 3. Mobile proton model for peptide fragmentation. 
 
While “charge directed” peptide fragmentation is dominated in CID, peptide may 
dissociate in “charge remote” way that does not require the migration of a proton to 
peptide bond. The “pathways in competition” model (Paizs & Suhai 2005) explains 
several alternative fragmentations. For example, the side chains of aspartic acid, glutamic 
acid, asparagine, glutamine, histidine, lysine and arginine can attack their C-terminal 
carbonyls to break the peptide bonds and form b and y ions. Loss of water may occur in 
the C-terminal COOH group, N-terminal glutamic acid or serine/threonine containing 
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peptides. Loss of ammonia may occur from the side chains of asparagine, glutamine, 
lysine and arginine residues when the side chains are protonated. Peptides with labile 
PTMs often lose the modification groups because this process requires lower energy than 
breaking peptide bond. In low-energy CID, moving of proton(s), nucleophilic attack, 
breaking and forming chemical bonds are the principle chemical reactions that produce 
fragment ions. 
 Understanding the rules underlying the gas-phase peptide dissociation is 
important for the development of software tools. Current peptide identification tools often 
either implement a simple prediction model or totally ignore the intensities of product 
ions in their scoring schemes. Improving the prediction of product ion intensities 
increases the discrimination power of scoring systems for peptide identification (Havilio 
et al. 2003, Elias et al. 2004, Frank 2009a, b). 
 
I.2 Proteomics Data Analysis  
I.2.1 Overview 
Automated bioinformatics tools play essential roles in proteomics data analysis 
(Domon 2006, Nesvizhskii et al. 2007). Frequently hundreds of thousands of tandem 
mass spectra are generated in a single proteomics experiment. The vast numbers of 
spectra place a heavy burden on data analysis, requiring an automated high throughput 
way for spectral interpretation.  
Figure 4 summarizes the typical proteomics data analysis workflow. It starts with 
assigning peptide sequences to experimental spectra, which can be done with different 
strategies discussed in next section. Next, peptide identifications are validated to estimate 
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the confidence of the assignments, and high confident identifications are used to infer 
proteins. In many studies such as PTM analyses, advances searches may be conducted to 
interpret spectra that are evaded in the first round of analysis.  
 
Identification
Peptide
ALVQQMEQLR
ESQLPTVMDFR
VPGLYYFTYHASSR
TMGYQDFADVVCYTQK
Protein
IPI:IPI00005721.1
IPI:IPI00007240.2
SWISS-PROT:P59665
SWISS-PROT:P05160
Peptide Identification
Peptide Validation and 
Protein Inference
Advanced Searches
 
Figure 4. The typical MS-based proteomics data analysis workflow. 
 
 Bioinformatics tools have been used for MS-based proteomics data analysis since 
1990s. During the past few years, many scoring algorithms have been developed to take 
advantage of improvements in MS instrumentation and fragmentation technologies. A 
partial list of these tools is summarized in Table 1. 
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Program Web site Reference 
Database search tools 
Sequest thermo.com (Eng et al. 1994) 
Mascot matrixscience.com (Perkins et al. 1999) 
ProteinProspector prospector.ucsf.edu (Clauser et al. 1999) 
SpectrumMill www.chem.agilent.com  
Phoenyx www.genebio.com/products/phenyx (Colinge et al. 2003) 
X!Tandem www.thegpm.org (Craig & Beavis 2004) 
OMSSA pubchem.ncbi.nlm.nih.gov/omssa (Geer et al. 2004) 
VEMS 3.0 yass.sdu.dk (Matthiesen et al. 2005) 
MyriMatch fenchurch.mc.vanderbilt.edu/software.php (Tabb et al. 2007) 
ProteinPilot www.absciex.com  
pFind 2.0 pfind.ict.ac.cn (Wang et al. 2007) 
Mass Matrix www.massmatrix.net/mm-cgi/home.py (Xu & Freitas 2008) 
Andromeda www.biochem.mpg.de/en/rd/maxquant (Cox et al. 2011) 
MassWiz sourceforge.net/projects/masswiz (Yadav et al. 2011) 
   
De novo sequencing tools 
Lutefisk www.hairyfatguy.com/Lutefisk (Johnson & Taylor 2002) 
PEAKS www.bioinformaticssolutions.com (Ma et al. 2003) 
Sequit www.sequit.org  
PepNovo proteomics.ucsd.edu/Software/PepNovo.html (Frank & Pevzner 2005) 
pNovo  (Chi et al. 2010) 
Vonode compbio.ornl.gov/Vonode (Pan et al. 2010) 
LysNDeNovo gforge.nbic.nl/projects/lysndenovo (van Breukelen et al. 2010) 
   
Sequence tagging-based database search tools 
Popitam www.expasy.org/tools/popitam (Hernandez et al. 2003) 
InsPecT proteomics.ucsd.edu/Software/Inspect.html (Tanner et al. 2005) 
ByOnic www.parc.com/work/focus-area/mass-spectra-
analysis 
(Bern et al. 2007) 
MODi http://modi.uos.ac.kr/modi (Na et al. 2008) 
TagRecon fenchurch.mc.vanderbilt.edu/software.php (Dasari et al. 2010) 
   
Spectral library search tools 
X!Hunter h201.thegpm.org/tandem/thegpm_hunter.html (Craig et al. 2006) 
Biblispec proteome.gs.washington.edu/software/bibliospec/
documentation/index.html 
(Frewen et al. 2006) 
SpectraST www.peptideatlas.org/spectrast (Lam et al. 2007) 
Pepitome fenchurch.mc.vanderbilt.edu/software.php (Dasari et al. 2012) 
   
Peptide validation and protein inference tools 
PeptideProphet www.proteomecenter.org/software.php (Keller et al. 2002) 
ProteinProphet www.proteomecenter.org/software.php (Nesvizhskii et al. 2003) 
MS-GF proteomics.ucsd.edu/Software/MSGeneratingFun
ction.html 
(Kim et al. 2008) 
MaxQuant www.biochem.mpg.de/en/rd/maxquant (Cox & Mann 2008) 
IDPicker fenchurch.mc.vanderbilt.edu/software.php (Ma et al. 2009) 
Scaffold www.proteomesoftware.com (Searle 2010) 
MassSieve www.ncbi.nlm.nih.gov/staff/slottad/MassSieve (Slotta et al. 2010) 
PeptideClassifier www.mop.unizh.ch/software.html (Qeli & Ahrens 2010) 
 
Table 1. Bioinformatics tools for MS-based proteomics data analysis.  
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I.2.2 Peptide Identification 
The first step of data analysis is to assign peptide sequences to experimental 
spectra. As shown in Figure 5, the peptide identification strategies can be roughly 
summarized to four categories: database search, de novo sequencing, sequence tagging-
based database search and spectral library search.  
 
 
Figure 5. Four peptide identification strategies. Adapted from Figure 2 in Nesvizhskii 
(2010). 
 
Database Search 
The most widely used approach for peptide identification is to conduct a database 
search using software tools such as Sequest (Eng et al. 1994), Mascot (Perkins et al. 
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1999), X!Tandem (Craig & Beavis 2004), OMSSA (Geer et al. 2004) and MyriMatch 
(Tabb et al. 2007). Figure 6 illustrates the database search strategy for peptide 
identification. To interpret spectra, database search tools first perform an in-silico 
digestion of a protein database to enumerate all candidate peptide sequences, where 
masses of these peptides are similar to those of observed precursor ions. A theoretical 
spectrum constructed for each candidate sequence is then compared to the observed 
spectrum, producing a matching score to describe how well a peptide interprets the 
spectrum.  
  
Protein sequences
Candidate peptides
In silico digest
Match scorer
Identified peptides
Fragmentation model
Peptides
E P TP
mass/charge
Intensity
 
 
Figure 6. Peptide identification by the database search strategy.  
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The number of candidate peptides that are compared to a spectrum is affected by 
database search parameters, particularly precursor ion mass tolerance, enzyme digestion 
constraint and the number of allowed modifications (Nesvizhskii 2007). Although a large 
number of candidate peptides may be compared to a spectrum, database search tools 
usually only export the top few peptides ranked according to search scores. In most cases, 
only the top ranked peptide of each spectrum will be considered for the subsequent 
validation and protein inference. 
A critical component in a database search program is the scoring function to 
measure the similarity between the experimental and theoretical spectra. A number of 
scoring schemes have been developed including the use of correlation functions (cross 
correlation in Sequest and dot product in X!Tandem) or probability-based models 
(Mascot and MyriMatch). Usually database search tools implement multiple scoring 
functions to evaluate the peptide-spectrum-matches (PSMs) in different aspects. These 
scores vary from arbitrary values such as XCorr in Sequest to statistical measures such as 
e-values in X!Tandem. Individual scores or the combination of multiple scores can be 
used for the subsequent peptide validation. 
Database search parameters have a great impact on search results. First, the 
precursor mass tolerance determines which peptides will be compared to the 
experimental spectrum, i.e., only peptides with masses within the precursor mass 
tolerance will be scored. High mass accuracy instruments allow a very narrow mass 
window specified in database search compared to low mass accuracy data (e.g. 10 ppm 
for orbitrap data compared to 3 Da for LTQ). This leads to fewer possible candidate 
peptides that are compared to the observed spectrum, thus dramatically reduces searching 
17 
 
time and decreases the number of false matches. Second, enzyme digestion constraint 
also controls the number of candidate peptides to be compared. For example, a tryptic 
search produces less candidate peptides than an unconstrained or semi-tryptic search. As 
a result, it usually spends less time than non-tryptic searches. A tryptic search, however, 
eliminates the possibility to identify peptides that undergo unexpected cleavages. 
Meanwhile, other database search parameters such as the number of allowed 
modifications, deisotoping setting and the reference protein database can also affect the 
search results (Nesvizhskii 2010). 
Although database search offers an automated high-throughput approach for 
peptide identification, they rely heavily on protein databases, in which some of the 
genome sequences and annotations may not be accurate. More importantly, mutations 
and modified peptides in biological samples are often ignored by existing database search 
methods. In addition, database search is a very time-consuming process because the large 
number of comparisons between observed spectra and their candidate peptides. These 
issues are addressed by the development of the ScanRanker tool described in Chapter III. 
 
De Novo Sequencing 
Unlike database search that requires a reference protein database for peptide 
identification, de novo sequencing infers peptide sequences directly from experimental 
spectra. The inferred peptides can be mapped to proteins by downstream tools such as 
MS-BLAST (Shevchenko et al. 2001). This is particularly useful when the organisms of 
interest have unsequenced or partially sequenced genomes. However, since this approach 
requires high spectral quality for accurate interpretation, and is very computationally 
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intensive, it has not yet been used for large-scale proteomics data analysis. The 
ScanRanker tool described in Chapter III helps to alleviate this problem. 
As summarized in Table 1, several de novo sequencing tools have been described. 
Early tools such as PepNovo (Frank & Pevzner 2005) and PEAKS (Ma et al. 2003) were 
developed for low resolution data under CID fragmentation. Recent efforts have been 
made to develop new de novo sequencing algorithms for high mass accuracy data (Frank 
et al. 2007, Pan et al. 2010) or data collected under HCD (Chi et al. 2010) and ETD (van 
Breukelen et al. 2010) fragmentation. These researches demonstrated that de novo 
sequencing can be greatly improved by the use of high mass accuracy instruments and 
advanced fragmentation methods. 
 
Sequence Tagging-Based Database Search 
Sequence tagging-based database search combines de novo sequencing and 
database search strategies. It first infers short peptide sequences (“tags”) from spectra. 
These tags are then used to match candidate peptides via database search. A tag 
comprises three parts in mass-sequence-mass format: the mass flanking the N-terminal of 
the partial sequence, the partial sequence, and the mass flanking the C-terminal of the 
partial sequence. A candidate peptide is selected to score against the spectrum if both the 
partial sequence and flanking masses in the observed spectrum match to the peptide. 
Compared to traditional database search methods that use precursor masses to select 
candidate peptides, sequence tagging employs tags as the text-based filter, which 
improves specificity and reduces the number of candidate sequences by a few orders of 
magnitude.  
19 
 
Sequence tagging-based approach is particularly useful for the identification of 
mutations or post-translationally modified peptides (Mann & Wilm 1994, Nesvizhskii 
2010). Bioinformatics tools such as InsPecT (Tanner et al. 2005), MODi (Na et al. 2008) 
and TagRecon (Dasari et al. 2010) are examples that employ sequence tagging to enable 
modification searches. These programs treat the mass shifts between experimental spectra 
and candidate peptides as potential modifications, and place the mass shifts on amino 
acids that best explain the spectra. Both de novo sequencing and sequence tagging-based 
database search benefit from the high mass accuracy of modern mass spectrometers. In 
Chapter III, I will discuss the use of sequence-tagging approach for spectral quality 
assessment. 
 
Spectral Library Search 
Spectral library search is a fast and sensitive approach for peptide identification 
compared to a conventional database search. Rather than matching observed spectra to 
computationally modeled theoretical spectra, MS/MS scans can be interpreted by 
matching against a spectral library, which is a large collection of observed spectra that 
are confidently identified in previous experiments. Bioinformatics tools such as 
SpectraST (Lam et al. 2007), Bibliospec (Frewen et al. 2006), X!Hunter (Craig et al. 
2006) and Pepitome (Dasari et al. 2012) were developed for spectral library searching. 
The National Institute of Standards and Technology (NIST) made several spectral 
libraries publically available for multiple species (http://peptide.nist.gov).  
Spectral library search is very computationally efficient. The accuracy of this 
method is considered to be higher than conventional database search. It is particular 
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useful for fast identification of well-studied samples. For example, bovine serum albumin 
(BSA) samples are routinely analyzed for instrumentation quality control (QC). Spectral 
library search is an ideal method for quick identification of these QC samples. A 
disadvantage of spectral library search is that only peptides that are previously identified 
can be assigned to newly observed spectra, and its performance is largely affected by the 
completeness and accuracy of assembled spectral libraries. In addition, a spectral library 
constructed for a particular type of mass spectrometer may not be applicable to data 
collected on other types of instruments due to the different gas-phase fragmentation 
principles. 
 
I.2.3 Peptide Validation 
Overview 
 Peptide identification tools evaluate all possible candidate peptides for each input 
spectrum, and usually only the best-scoring sequence is used to interpret the spectrum. 
However, not all PSMs are correct assignments. In contrast, sometimes the majority of 
best-scoring peptides assigned by database search tools are incorrect PSMs (Domon 2006, 
Nesvizhskii et al. 2007). The reasons for the high failure rate include: 
(1) Sequence not in database. Peptides with mutations and unexpected modifications 
will not be identified. Their spectra may be assigned incorrect best-scoring 
peptides. 
(2) Contaminant spectra. Database search only identifies spectra derived from 
peptides, while chemical contaminants that are introduced to MS analysis during 
sample preparation are assigned wrong peptide sequences. 
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(3) Low quality spectra. Poorly fragmented peptides often produce low quality 
spectra that have either high signal-to-noise (S/N) ratio or less peaks to match 
peptide sequences, thus may be assigned incorrect peptides in database search. 
(4) Insufficient scoring scheme. Database search engines often apply a simplified 
fragmentation model to predict the theoretical spectrum, while in reality peptide 
fragmentation depends on many factors such as amino acid composition and 
location, and produces more complicated spectra.  
(5) Chimera spectra. Multiple peptides with the same m/z value may be concurrently 
isolated at the same time, thus produce a chimera spectrum with fragment ions 
from all these peptides. Database search tools may assign one of the correct 
peptides or a wrong sequence to a chimera spectrum. 
(6) Incorrect precursor charge state or mass. The precursor ion mass of a spectrum 
can be measured inaccurately, and wrong candidate peptides may be selected to 
match the spectrum. Meanwhile, peptide charge state can be incorrectly 
determined, especially for low resolution instruments such as LTQ. 
(7) Inappropriate search parameters. A wide precursor mass tolerance introduces 
more candidate peptides for comparison, thus has a potential to produce more 
incorrect PSMs. A narrow precursor mass tolerance has the risk to exclude correct 
peptides for comparison. A tryptic search will not identify peptides with 
unexpected cleavage, resulting in incorrect peptides assigned to these spectra. 
 
Figure 7 illustrates the score distribution of correct and incorrect PSMs, which may 
overlap significantly depending on how well they can be discriminated by database 
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search scores. Incorrect PSMs may score higher than some correct PSMs due to spurious 
matches, homologous peptide sequences, or because spectra for these correct PSMs are 
relatively low quality spectra. It is desired that database search programs achieve a high 
discrimination between correct and incorrect PSMs in peptide identification. Improving 
database search scoring schemes and developing advanced peptide validation methods 
may both reduce the overlap region of correct and incorrect PSMs, and subsequently 
reduce false peptide sequences for protein inference. 
Some correct PSMs may be excluded for subsequent analysis because they fail to 
pass the confidence threshold (see Figure 7, region A’). Meanwhile, some spectra are 
assigned incorrect peptides because these peptides are scored better than correct ones due 
to many possible reasons described above. These issues can be alleviated by the 
introduction of the IDBoost tool described in Chapter II.   
Since peptides with unexpected modifications and mutations will not be identified 
in database search, these spectra will generate incorrect PSMs. Advanced identification 
methods such as sequence tagging-based modification search or de novo sequencing 
helps to interpret these spectra, while how to find these spectra remains an issue. In 
Chapter III, I will demonstrate the use of the ScanRanker tool to solve this problem. 
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Figure 7. Score distribution for correct and incorrect PSMs. Adapted from Figure 1 in 
Brosch & Choudhary (2010). Shaded area (a) represents all accepted PSMs (both correct 
and incorrect PSMs) above a threshold, and solid grey filled area (b) represents incorrect 
PSMs passing the threshold that are falsely accepted. A’ together with A sum up all 
correct PSMs, and A’ represents correct PSMs that fail to pass the threshold. B and B’ 
sum up all incorrect PSMs, and B represents incorrect PSMs that are wrongly selected 
within a given threshold. The false positive rate (FPR), false discovery rate (FDR) and 
posterior error probability (PEP) can be calculated as shown in the figure. 
  
Peptide Validation Strategies 
Because a large proportion of MS/MS spectra cannot be matched successfully to 
peptide sequences, raw identifications must be filtered to retain the most accurate PSMs 
for protein inference, i.e., a threshold need be determined to generate a list of high 
confident identifications. The selected threshold should yield a good tradeoff between 
sensitivity and error rate. A high score threshold reduces the number of false matches but 
Threshold 
A’ 
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also decreases sensitivity, yielding less number of correct PSMs for protein inference. In 
contrast, a low score threshold allows more PSMs to be selected at the cost of a higher 
error rate. 
Early on proteomics researchers often applied an ad hoc cutoff value of database 
search scores to generate a list of confident PSMs. For example, use XCorr > 2.5 for 
Sequest search and IonScore > 45 for Mascot search. This approach, however, has many 
disadvantages. First, the score distributions generated by a database search tool vary with 
respect to the instruments, sample complexities, data quality and the protein database 
searched. Therefore, there is no single score threshold can be applied to all datasets. 
Second, even though a single score threshold can be applied to data from different 
experiments, the error rates are still remaining unknown, making it difficult to compare 
data between experiments. Third, applying an ad hoc cutoff makes it impossible to 
compare search results from different search algorithms and instruments, and often has 
poor tradeoff between sensitivity and specificity.  
To solve these issues, modern proteomics has moved away from the ad hoc score 
cutoff toward probabilistic approaches. Translating the database search scores to statistics 
provides interpretable probability scores. Multiple search scores, database features and 
experimental conditions all can be taken into account in statistical models. 
Several methods have been developed to convert arbitrary search scores of raw 
identifications into statistical measures. As shown in Figure 7, three commonly used 
statistical measures are p-value, false discovery rate (FDR) and posterior error probability 
(PEP).  
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Database search scores can be converted to p-values to measure the confidence 
for peptides scored to a single spectrum. In order to interpret a spectrum, database search 
engines enumerate all candidate peptides, and each of them is scored against the spectrum. 
This produces a large number of scores that can be used to estimate the null distribution 
for p-value inference. The score of the best matched peptide is then converted to a p-
value based on the null distribution. Both parametric distribution (Sadygov & Yates 2003, 
Geer et al. 2004) and empirically fitted distribution (Fenyö & Beavis 2003) have been 
developed to derive p-values. A p-value can be interpreted as the probability to observe a 
match with an equal or higher score by random chance. Therefore, the further a score is 
away from the center of the null distribution, the higher the statistical significance it 
represents.  
A disadvantage of the p-value approach is that it is affected by the number of 
PSMs compared to a spectrum. Large number of comparisons may yield smaller p-values 
by random chance alone, which requires a multiple testing correction to adjust p-values. 
However, classical methods such as “Bonferroni correction” were not designed for large 
size of datasets, and often lead to overly conservative results.  
An alternative statistical measure that works well for large-scale data is FDR, 
which estimates the global error rate for a set of PSMs. In proteomics, for example, if 100 
PSMs were scored above a threshold and 5 of them were found to be incorrect matches, 
then the expected FDR will be 5% for this analysis. A common way to estimate incorrect 
matches among a collection of PSMs is to conduct database searches through the target-
decoy strategy (Elias & Gygi 2007). This approach searches MS/MS scans against a 
target protein database appended with decoy proteins, which can be reversed (Moore et al. 
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2002), randomized (Colinge et al. 2003) or shuffled (Klammer & MacCoss 2006) 
sequences. It assumes that false identifications follow the same distribution as matches to 
decoy sequences. To compute FDR, all PSMs from a database search are ordered by a 
matching score or a combination of multiple matching scores. A q-value is then 
calculated for each PSM as the minimal FDR threshold at which a PSM is accepted. 
PSMs passing a FDR threshold are then considered valid identifications for protein 
inference.  
FDR-based peptide validation has become the method of choice for large-scale 
proteomics studies, and many bioinformatics tools have implemented this approach. In 
my Master’s thesis, I presented IDPicker 2.0 that combines multiple search scores and 
applies additional filters to improve FDR-based peptide validation (Ma et al. 2009). 
Another tool, Percolator (Käll et al. 2007), employs a semi-supervised machine leaning 
method to discriminate between correct and incorrect PSMs based on target-decoy search 
results. It was originally designed to work with Sequest results and has been recently 
adapted to handle Mascot search results (Brosch et al. 2009). 
Although q-values are associated with individual PSMs, FDR is a summary 
statistic for the entire collection of PSMs, and does not measure the confidence of 
individual PSMs. When the focus is to evaluate individual PSMs, PEP, also known as 
local FDR, can be estimated to represent the probability of a PSM being incorrect. For 
example, a PSM with a PEP value of 0.01 means there is 1% chance that this PSM is an 
incorrect assignment. One way to compute PEP is to use a mixture model-based method 
as implemented in PeptideProphet (Keller et al. 2002). The PEP for each individual PSM 
can be used to filter low confident identifications. Moreover, the PEP and FDR method 
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can work together to make more accurate and robust estimation (Choi & Nesvizhskii 
2008). In this case, the decoy sequences are used to estimate the distribution of incorrect 
PSMs, yielding a more accurate mixture model for PEP calculation. 
 
I.2.4 Protein Inference 
In most proteomics experiments, the ultimate goal of a study is to know what 
proteins are present in the analyzed sample. Therefore, high confident peptide sequences 
passing the validation step need to be mapped to their corresponding proteins, and the 
confidence at the level of proteins need to be re-assessed. This process, however, is not 
straightforward and faces many challenges.  
First, peptides whose sequences are present in more than one protein may 
complicate the protein inference process. In this case, since a single peptide can be 
mapped to multiple proteins, it is difficult to know which protein(s) is present in the 
analyzed sample. As illustrated in Figure 8, for example, protein B and C will be 
indistinguishable because they both map to the same set of peptides. The shared peptides 
often result from homologous proteins, splicing variants or redundant entries in the 
protein database. This is particularly a serious problem for higher eukaryote organisms 
due to the high abundance of shared peptides (Nesvizhskii & Aebersold 2005). It is a 
general problem for shotgun proteomics experiments because the connectivity between 
peptides and proteins is lost during sample preparation and digestion. Separating proteins 
in a 2D gel before MS analysis helps to alleviate this problem, where additional 
information such as the molecular weights and isoelectric point can be used in 
determination of the protein identities (Görg et al. 2004).  
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Figure 8. A simplified example of protein inference. Green and red colors represent 
correct and incorrect peptides/proteins, respectively. Peptide 2 and 3 are shared by the 
same set of proteins. 
 
Second, incorrect PSMs may be accepted after peptide validation, yielding wrong 
peptides for protein inference (e.g. protein D in Figure 8). This is a more serious problem 
when searching spectra against a large protein database, where spurious peptides have a 
higher chance to be scored superior to correct ones. At the same time, many correct 
PSMs tend to map to a relatively small number of proteins that are dominant in the 
analyzed sample (Nesvizhskii et al. 2003). For example, a recent study showed that only 
~5% of all collected MS/MS scans lead to the identification of unique peptides in large-
scale studies (Swaney et al. 2010). As a result, almost every highly scored incorrect PSM 
may introduce one additional incorrect protein. Even with a careful control of FDR at the 
PSM level, these incorrect PSMs can produce a high FDR at the protein level. Requiring 
more than one distinct peptide per protein (“two peptide rule”) helps to remove some 
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incorrect proteins, but this will reduce the sensitivity and excludes the identification of 
low abundance proteins supported by a single peptide. 
A commonly used approach for protein inference and error rate estimation is to 
conduct database searches using a target-decoy strategy, and then apply various filters to 
assemble proteins to a desired protein-level FDR. Common filters include peptide-level 
FDR, minimal number of spectra per protein and minimal number of distinct peptides per 
protein. In this case, the protein-level FDR can be estimated according to the number of 
decoy proteins included in the final list. To achieve a lower protein-level FDR, one can 
either apply a more stringent peptide-level FDR, or require more than one spectrum or 
distinct peptides per protein. Both approaches lower the number of incorrect PSMs for 
protein inference, and thus reduce the error rate. To handle the problem of shared 
peptides that may produce many homologous proteins and isomers in final list, one can 
either report all proteins identified with at least one distinct peptide, or simply select a 
representative protein among homologs (States et al. 2006).  
The parsimony principle for protein inference has been widely accepted in 
proteomics community. It is also required by several journals for publishing proteomics 
research results (Carr et al. 2004). The central concept, as exemplified by several 
computational tools (Nesvizhskii et al. 2003, Yang et al. 2004, Zhang et al. 2007, Ma et 
al. 2009), is to derive a minimal list of proteins that can account for all observed peptides.  
A disadvantage of the protein-level FDR is that it is a global estimation of error 
rate for all accepted proteins. The confidence of individual proteins may be further 
estimated based on many metrics such as sequence coverage and the number of identified 
spectra for corresponding proteins. Statistical models have been developed to compute 
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probabilities for individual proteins, which estimate the likelihood that a protein is a true 
identification. For example, ProteinProphet (Nesvizhskii et al. 2003) reads the PSMs and 
their posterior probabilities generated from PeptideProphet to compute a cumulative 
score. That is, the probabilities of all PSMs mapped to a protein are combined together to 
yield the probability that the corresponding protein is present in the analyzed sample.  
The initial PSM probabilities from PeptideProphet may be adjusted to take into 
account the number of peptides mapped to the same protein group (undistinguishable 
proteins). The adjustment produces improved protein probabilities that agree with the 
actual protein-level FDR. ProteinProphet retains proteins identified by a single peptide if 
that peptide is assigned a high posterior probability in PeptideProphet. These proteins 
could be excluded in FDR-based protein inference due to the use of “two peptide rule”. 
Other statistical methods using hierarchical modeling (Shen et al. 2008) or incorporating 
gene models to protein inference (Gerster et al. 2010) were also reported.  
Most bioinformatics tools separate peptide validation and protein inference to two 
steps as described above. A recent research treated protein inference as a single 
optimization problem, and proposed a machine learning method, Barista, to optimize 
these two steps in a single analysis (Spivak et al. 2011). The essential concept is that 
peptide validation and protein inference are cooperative such that one task benefits from 
the other during optimization, and thus should be exploited simultaneously. Barista reads 
target-decoy search results and develops a model that maximizes the number of target 
proteins. It incorporates a wide variety of evidence to directly control the relevant error 
rate, providing 18-34% more protein identifications than other approaches (Spivak et al. 
2011). 
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I.3 Instrumentation Quality Control 
No matter how advance the data processing algorithms could be, they all assume 
the spectra from mass spectrometers are collected under stable instrument performance. 
Therefore, quality control of instrumentation performance is critical for proteomics 
studies. Many studies are designed to be comparative in nature such as exploring protein 
expression differences between tumor and normal tissues. These studies assume the 
observed differences come from the proteome differences of analyzed samples rather 
than analytical system variability. Therefore, the mass spectrometer needs to be 
frequently checked during data collection to ensure stable analytical system performance. 
Even with high mass accuracy instruments, achieving truly high accuracy often requires 
fine instrument tuning, room temperature control and the use of internal or external 
calibration. 
The most commonly used approach is to run simple samples such as BSA 
periodically, and count the number of confident identifications to measure instrument 
variability. This approach, however, does not reveal whether system performance is 
optimal or which components cause the large variation. NIST introduced the MSQC 
software (Rudnick et al. 2010) to compute diverse metrics from experimental LC-MS/MS 
data, enabling the QC evaluation of proteomics instrumentation. In practice, however, 
several aspects of the MSQC software prevent its use for routine instrument monitoring. 
This problem is further addressed in Chapter IV with the development of the QuaMeter 
tool. 
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I.4 Dissertation Outline 
The objectives of my work are to develop novel algorithms and bioinformatics 
tools for MS-based proteomics data analysis. The following chapters present three tools 
that facilitate proteomics data processing. In each chapter a separate introduction is given 
to describe the background of the respective topic. 
In Chapter II, I present the IDBoost tool to rescue correct spectral identifications 
and correct database search errors through spectral clustering. In Chapter III, I describe 
the ScanRanker tool that evaluates the quality of tandem mass spectra via the sequence 
tagging approach. In Chapter IV, I present the QuaMeter tool for MS instrumentation 
quality control. Each tool is evaluated with a variety of datasets and their applications are 
demonstrated. 
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CHAPTER II 
 
IDBOOST: VALIDATION AND RESCUE OF TANDEM MASS SPECTRAL 
IDENTIFICATIONS VIA SPECTRAL CLUSTERING 
 
II.1 Introduction 
Despite recent improvements in analytical methods, usually only a small fraction 
of spectra can be identified in a typical shotgun proteomics experiment, implying the 
need for advanced methods to improve identification rate. This may be caused by many 
factors such as unexpected modifications, incomplete protein databases or low spectral 
quality. However, many spectra assigned correct peptides may fail to pass the FDR 
threshold (see Figure 7). For example, given a set of spectra assigned to the same peptide, 
it is common that only spectra assigned high database search scores are identified, while 
the others that fail to pass the threshold are discarded. These discarded spectra may be 
correct identifications because the matched peptide is identified by other spectra. 
Rescuing these spectral identifications provides more information for subsequent data 
analysis such as manual validation of phosphopeptides and spectral count-based protein 
quantification.  
In addition to the low identification rate, two kinds of errors are often included in 
database search results. First, wrong peptides may spuriously score higher than correct 
sequences. This introduces false proteins and reduces the spectral count of correctly 
identified proteins, leading to inaccurate estimations in spectral count-based protein 
quantification. Second, if multiple modification sites are present in a peptide, one with a 
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misplaced modification site may score better than a correct one due to low spectral 
quality or insufficiency of scoring algorithms. The ambiguous modification locations are 
detrimental to experiments to localize modifications, such as phosphorylation studies. For 
both kinds of errors, the correct sequences frequently score very similarly to the 
erroneous top-ranked matches. Since many database search engines generate several 
PSMs per spectrum, it is very likely that the correct sequences are stored in the search 
output, but are invisible in subsequent analysis because they are not top-ranked hits. They 
can, however, be rescued by examining search results and re-ranking PSMs for each 
spectrum. 
Several efforts have been made to correct these errors. For example, Percolator 
provided a re-ranking function to correct spurious random matches via a machine 
learning approach for Sequest or Mascot, deciding which PSM was ranked highest for a 
spectrum by search scores and peptide properties. Ascore (Beausoleil et al. 2006) 
presented a probability-based score to correct phosphorylation site localization, but it 
required the presence of site-determining ions exclusive to specific site locations. These 
methods correct errors based on search results from either a single file or a single 
spectrum. In fact, shotgun proteomics experiments are often designed to include multiple 
replicate LC-MS/MS runs, and many identified peptides are associated with more than 
one spectrum. For example, in a recent study only ~5% of all collected MS/MS scans 
lead to the identification of unique peptides (Swaney et al. 2010). 
Here I seek to correct these errors in a single analysis by incorporating search 
results across multiple runs. I hypothesized that spectra derived from the same peptide 
should share high similarity in fragment ion patterns. Given a set of similar spectra, a 
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secondary PSM (ranked below the first position for a spectrum) may represent the correct 
interpretation if similar spectra also are matched to this peptide. Likewise, the 
modification site localization errors may be corrected by taking into account site 
assignments of similar spectra. This approach rescues correct secondary PSMs based on 
existing search results with no requirement for running additional database searches. For 
the best applicability, the approach must function with a variety of search engines and use 
more informative tandem mass spectra to guide interpretation of poorer quality scans.  
In this work, I seek to rescue spectra that are supported by other confident PSMs 
passing the FDR threshold. However, simply adding all spectra assigned to these peptides 
back to the analysis is not appropriate, because some of them may be unreliable spurious 
matches. In addition, if multiple PSMs per spectrum are considered, more than one 
peptide could be identified and it is not clear which PSM should be rescued. Here I 
present IDBoost, a software tool to rescue spectral identifications and correct database 
search errors via spectral clustering. I demonstrate the use of IDBoost in phosphorylation 
studies to rescue phosphopeptide identifications and to resolve phosphosite localization 
ambiguity. I show that IDBoost helps recognize differentially expressed proteins in 
comparative analysis. I also evaluate IDBoost using a variety of datasets representing 
various instrument platforms and sample complexities. 
 
II.2 Algorithm 
II.2.1 Overview 
The goal of this work is to rescue PSMs and to correct database search errors by 
incorporating identification evidence from similar spectra. In brief, IDBoost first groups 
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similar spectra into clusters and then examines all pairs of spectrum-peptide matches in a 
cluster. A PSM will be rescued if a similar spectrum matched to the same peptide is a 
valid identification. Multiple PSMs per spectrum, e.g., the top 5 ranked PSMs for a 
spectrum, can be included in this process, enabling re-ranking of PSMs to correct 
spurious matches or modification localization errors. Only one PSM per spectrum is 
allowed to be rescued. A “Bayesian average” rating method prioritizes peptides for 
rescue. IDBoost is written in C#/.NET and implemented in IDPicker (Zhang et al. 2007, 
Ma et al. 2009), which is available for download from http://fenchurch.mc.vanderbilt.edu. 
 
II.2.2 Spectral Clustering 
Tandem mass spectra are clustered based on the similarity between each pair of 
spectra. Rather than process all spectra, only spectra matching to a confidently identified 
peptide within the top N ranked PSMs are selected for clustering (N is a user 
configurable parameter). Next, selected spectra are sorted by their precursor m/z values 
and are compared for similarity to any others within a user-specified m/z tolerance. The 
similarity between each pair is computed by a normalized dot product, which has 
previously been found to work well for spectral clustering (Tabb et al. 2003, 2005, Beer 
et al. 2004, Frank et al. 2008). To reduce the effect of low intensity peaks, only the top 
100 most intense peaks of each spectrum are retained for similarity comparison. Peak 
intensities are square rooted to emphasize smaller peaks (Tabb et al. 2003).  A single-
linkage clustering approach (Beer et al. 2004, Frank et al. 2008) is applied to group 
spectra. i.e., if spectrum A is similar to B, and B is similar to C, then all three spectra will 
form one cluster. The default similarity threshold is 0.6, and is user configurable. The 
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method is similar to the Pep-Miner algorithm (Beer et al. 2004), which has been proved 
to be an effective clustering approach in prior work (Beer et al. 2004, Frank et al. 2008). 
 
II.2.3 Rescue of Spectral Identifications 
Once similar spectra are grouped together, an unidentified PSM may be rescued 
by taking identification evidence from other spectra into account. As illustrated in Figure 
9, for example, all spectra in a cluster are first mapped to peptides in a bipartite graph. 
Multiple PSMs per spectrum can be included to enable the rescue of secondary PSMs. 
Next, a “Bayesian average” rating method (described below) is applied to prioritize 
peptide sequences that will be processed. This is a necessary step because only one PSM 
per spectrum is allowed to be rescued, while one spectrum may be mapped to multiple 
peptides (the top N peptides assigned to this spectrum). Peptides sharing the same 
sequence but different PTM locations are treated as distinct peptides.  
To rescue unidentified PSMs, IDBoost sifts through prioritized peptides and their 
linked spectra. An unidentified PSM will be rescued if a similar spectrum matched to the 
same peptide is a valid identification. A rescued spectrum then will be excluded from 
further analysis to ensure only one PSM per spectrum rescued. In Figure 9C, for example, 
the best scored Pep2 linked to three spectra. Since the PSM of Scan4-Pep2 is a valid 
identification, both Scan2 and Scan5 will be rescued. Next, Scan3 will be rescued to Pep1 
because the same peptide is supported by an identified spectrum (Scan1). However, since 
only one PSM per spectrum is allowed to be rescued, Scan2 will not be assigned to Pep1 
because it has already been processed and rescued to Pep2. Since no spectra linked to 
Pep3 are identified, all PSMs mapped to Pep3 remain untouched. 
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A: Map spectra and peptides in a cluster
B: Prioritize peptides by Bayesian average scores 
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Figure 9. A diagram of rescuing unidentified spectra in a cluster. (A) A bipartite graph 
shows the PSM mapping between seven spectra and three peptides in a spectral cluster. 
Each link represents a peptide-spectrum match. For simplicity, all spectra are linked to 
only one peptide except Scan2, which is mapped to both Pep1 and Pep2, representing a 
case that multiple PSMs can be included in the rescuing process. Highlighted Scan1 and 
Scan4 represent valid identifications that pass a threshold of confidence. (B) All peptides 
are scored and prioritized by the “Bayesian average” rating method. In this example, 
Pep2 receives the best Bayesian average score, and Pep3 is the lowest rated peptide. (C) 
IDBoost sifts through prioritized peptides and rescues unidentified spectra.  
 
Including multiple PSMs per spectrum in the rescuing process enables the rescue 
of secondary peptide identifications, but this dramatically increases the number of PSMs 
to be processed. Many of these PSMs are assigned low database search scores and are not 
likely to be confident identifications. To reduce processing time, IDBoost provides a 
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configurable filter to exclude PSMs of low score. For example, throughout this study, 
PSMs with MyriMatch MVH scores lower than 10 were excluded.  
It should be noted that IDBoost only increases spectral identifications mapping to 
currently identified peptides, while peptide and protein identifications remain unchanged 
unless a spectral count-based filter is applied in protein inference. IDBoost does not 
remove originally identified PSMs. If a PSM is rescued for an identified spectrum, both 
the original PSM and the rescued PSM will be presented, implying that the rescued 
peptide is better supported by a cluster of spectra than the original identification. The 
IDPicker tool in which IDBoost is implemented provides a graphical user interface (GUI) 
to present both rescued and originally identified PSMs. It also displays database search 
scores and offers a spectrum viewer to visualize peptide-spectrum matches, enabling 
manual validation of ambiguous identifications if multiple peptides are assigned to a 
single spectrum. 
 
II.2.4 Bayesian Average Score 
As illustrated in Figure 9B, all peptides in a cluster are prioritized for rescue by 
“Bayesian average” scores. “Bayesian average” is a rating method to calculate the mean 
of a set of data that is consistent with Bayes’ theorem. Given a set of options rated by a 
number of voters, instead of simply calculating the average rating of an option, the 
“Bayesian average” method incorporates the number of votes into the calculation, 
generating a weighted average score. As a result, options with more votes receive 
Bayesian average scores closer to their unweighted arithmetic average. In contrast, when 
there are few votes, the rating of an option will be a weighted average (a Bayesian 
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average score) that is closer to the average rating of all options. In this study, each 
peptide is an option, and spectra in a cluster are voters. The database search scores of 
PSMs represent ratings between spectra and peptides. The “Bayesian average” score of a 
peptide is computed to be: 
Cn
xmC
x
n
i i
+
+∗
=
∑
=1
 
where x is a database search score assigned to this peptide, n is the number of spectra 
mapped to this peptide, m is the mean of database search scores taken over all PSMs in 
this cluster. C is a weighting constant that should be a large number and is proportional to 
the size of the dataset. Here I use the maximal number of spectra assigned to a peptide in 
this cluster, i.e., the maximal votes of an option in the dataset, multiplied by 10 to keep it 
a large number. The Bayesian average reflects how peptides are scored in database search 
in relation to each other. A peptide identified by a relatively large number of spectra 
receives a Bayesian average score close to its unweighted average. In converse, the 
Bayesian average score for peptides with a relatively small number of spectra tends to 
gravitate towards the average rating of all PSMs.  
To prioritize peptides in a cluster, the Bayesian average scores are normalized to 
percentiles. For example, a Bayesian average score of 0.99 means this peptide is scored 
better than 99% of other peptides in a cluster. If the same set of spectra is searched by 
multiple database search engines, the Bayesian average scores are computed separately 
for each analysis, and then summed together to rank peptides. In this case, peptides 
shared by multiple search engines are more believable and will receive higher Bayesian 
average scores. IDBoost exports a tab-delimited text file to report rescued PSMs and their 
Bayesian average scores. 
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During the method development, I also considered several other voting methods 
such as “Borda count” and “Condorcet method”. I decided to choose the Bayesian 
average rating because it allows weighting voters and its success has been proved in 
many user reviewing systems.  
 
II.3 Data Sources 
Several datasets were used to demonstrate the utility of IDBoost (see Table 2). 
Binary spectral data present in the raw files were converted to mzML (Deutsch 2008) 
format using MSConvert tool of the ProteoWizard (Kessner et al. 2008) library. The 
MyriMatch tool searched each file against a protein database that contained sequences in 
both forward and reverse orientations for estimation of protein identification error rates. 
Search results were processed by IDPicker for peptide validation and protein assembly. 
Throughout this study, IDPicker was configured to derive PSM score thresholds to yield 
a 5% FDR. Detailed configurations of MyriMatch and IDPicker are given in Appendix A. 
 
“Synthetic Orbi” Dataset 
This dataset was previously used to test a phosphorylation site localization 
algorithm and the experimental description was published (Savitski et al. 2011). In brief, 
180 peptides with positional phosphosite isomers were synthesized and pooled to five 
mixtures, such that no phosphorylation site isomers were present in any one mixture. 
Mixtures were analyzed on a Thermo Fisher LTQ-Orbitrap hybrid mass spectrometer in 
which peptides were fragmented by CID. 
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Dataset  
# of files  
(sample x rep) 
Average # of 
MS/MS scans Databases used for search 
Rescue of Phosphopeptide Spectra 
Synthetic Orbi  5 x 1 1598 IPI.HUMAN.v3.79   
pTyr LTQ 1 x 3 18550 IPI.HUMAN.v3.79 
Rescue of Spectra in Comparative Analysis 
Yeast LTQ 1 x 3 26151 SGD.orf_trans_all+UPS1 
Yeast_UPS1 LTQ 5 x 3 26148 SGD.orf_trans_all+UPS1 
Rescue of Spectra in a Variety of Data 
UPS1 LTQ 3 x 3 24937 SGD.orf_trans_all+UPS1 
UPS1 Orbi 3 x 3 10935 SGD.orf_trans_all+UPS1 
Yeast LTQ 3 x 3 24948 SGD.orf_trans_all+UPS1 
Yeast Orbi 3 x 3 12464 SGD.orf_trans_all+UPS1 
Yeast MudPIT 
LCQ 19 x 6 2961 SGD.orf_trans_all 
 
Table 2. Experimental datasets for the evaluation of IDBoost.  
 
“pTyr LTQ” Dataset 
A human epithelial carcinoma cell line (A431) (ATCC, Manassas, VA) was 
cultured in 150 mm culture dishes in improved MEM (Invitrogen-GIBCO, Auckland, NZ) 
supplemented with 10% fetal bovine serum (Atlas Biologicals, Fort Collins, CO) at 37°C 
in 5% CO2.  A431 cells were grown to ~60-70% confluency prior to treatment. Cells 
were serum-starved (18 hrs), followed by treatment with 30 nmol epidermal growth 
factor (EGF)( Cell Signaling Technology, Danvers, MA) for 30 min. Cells were 
harvested on ice with Mg and Cl-free PBS  supplemented with a phosphatase inhibitor 
cocktail (1 mM sodium fluoride, 10 mM β-glycerophosphate, 1 mM sodium molybdate, 
and 1 mM activated sodium orthovanadate – individual components purchased from 
Sigma (St. Louis, MO)), pelleted by centrifugation at ~250 x g, flash-frozen and stored at 
-80°C. 
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The phosphotyrosine enriched dataset was generated by enriching 
phosphotyrosine peptides from tryptic digests of cell lysates as previously decribed (Rush 
et al. 2005) except that cells were lysed in 50:50 (v/v) acetonitrile and 50mM ammonium 
bicarbonate prior to in-solution trypsin (Promega, Madison, WI) digestion and samples 
were pY enriched using 4G10 antibody (Millipore, Billerica, MA). LC-MS/MS and MS3 
analyses were performed on a Thermo Fisher LTQ Velos (San Jose, CA) mass 
spectrometer equipped with an Eksigent Nano-1D Plus HPLC and AS-1 autosampler 
(Dublin, CA).  Peptides were separated on a 100 µm × 11 cm fused silica capillary 
column (Polymicro Technologies, LLC., Phoenix, AZ) and 100 µm x 6 cm fused silica 
capillary precolumn packed with 5 µm, 300 Å Jupiter C18 (Phenomenex, Torrance, CA). 
Liquid chromatography was performed using a 95 min gradient at a flow rate of either 
400 or 600 nL min−1 using a gradient mixture of 0.1% (v/v) formic acid in water (solvent 
A) and 0.1% (v/v) formic acid in acetonitrile (solvent B).  Briefly, a 15 min wash period 
(100% solvent A) was performed followed by a gradient to 98% A at 15 min (1.2 µl min-
1) and eluent was diverted to waste prior to the analytical column using a vented column 
set up similar to that previously described (Licklider et al. 2002).  Following removal of 
residual salts, the flow was redirected to flow through the analytical column and solvent 
B increased to 75% over 35 minutes and up to 90% in 65 minutes.  The column was re-
equlibrated to 98% solvent A for 10 minutes after each run. MS/MS peptide spectra were 
acquired using data-dependent scanning in which one full MS spectrum was followed by 
5 MS/MS spectra. A data-dependent scan for the neutral loss of phosphoric acid or 
phosphate resulted in acquisition of an MS/MS/MS of the neutral loss ion.  
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“Yeast LTQ”, “Yeast Orbi”, “UPS1 LTQ”, “UPS1 Orbi” and “Yeast_UPS1 LTQ” 
Datasets 
These datasets are publically available for download from Proteome Commons 
website (https://www.proteomecommons.org) and the experimental details are available 
in the original publication (Paulovich et al. 2010). Yeast lysate was reduced by 
dithiothreitol (DTT), alkylated by iodoacetamide and digested by trypsin. Both yeast and 
UPS1 (Sigma UPS1, Sigma-Aldrich, St. Louis, MO) were analyzed on LTQ and LTQ-
Orbitrap instruments. The “Yeast_UPS1” data represents a mixture of yeast and spiked 
UPS1 in five different concentrations: 0.24, 0.67, 2.54, 6.7 and 20 fmol/µl. This sample 
was analyzed on a LTQ instrument. 
 
“Yeast MudPIT LCQ” Dataset 
This dataset was published by Arnett et al. and the experimental details were 
described in the original publication (Arnett et al. 2008). In brief, Weil lab at Vanderbilt 
University collected spectra from 19 MudPIT experiments to study yeast Mot1p protein-
protein interactions, in which immunopurifications of Mot1p-interacting proteins were 
performed using multiple antibodies. Each pull-down was subjected to MudPIT analysis 
with six fractions and analyzed on a Thermo LCQ Deca XP Plus mass spectrometer. 
 
II.4 Results and Discussion 
To establish the effectiveness of IDBoost, I first evaluated the method using two 
phosphorylation datasets. I show that by encompassing search results from similar spectra, 
IDBoost achieved high accuracy in rescuing correct identifications. Next, I demonstrate 
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the use of IDBoost to enhance the recognition of differentially expressed proteins in 
comparative analysis. I then demonstrate IDBoost performance in a variety of datasets. 
These tests established IDBoost as an effective and robust method to rescue confident 
spectral identifications. 
 
II.4.1 Rescue of Phosphopeptide Spectra to Resolve Phosphosite Localization Ambiguity 
Once similar spectra are clustered together, the rescuing process starts from the 
peptide assigned the best Bayesian average score. To ensure that the correct peptides are 
rescued, “Bayesian average” method should be able to score true peptides more highly 
than random matches. This is a less serious problem in database searches to produce 
inventories, because a set of spectra in a cluster often maps to a single peptide. However, 
this becomes more complicated in phosphopeptide searches, in which spectra may be 
identified to the same peptide sequence with different phosphorylation sites, i.e., 
phosphosite isomers. In database search, phosphosite isomers often score very similarly 
even though true peptides generally receive better scores than false isomers. I expect the 
“Bayesian average” method in IDBoost to rate a true peptide sequence more highly than 
one with misplaced modification site. Incorporating search results from similar spectra 
could thus reduce phosphosite localization ambiguity.  
To evaluate the effectiveness of the “Bayesian average” method, I used a 
synthetic phosphopeptide dataset in which peptide sequences and phosphorylation sites 
are known (Savitski et al. 2011). All spectra were searched using MyriMatch against an 
IPI human protein database and post-processed by IDPicker.  
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I first examined all spectra that were assigned known sequences and correct PTM 
locations within their top 5 PSMs. Among all five raw files, 1678 of 7802 spectra were 
assigned to the correct synthetic sequences, while only 945 of them were confident 
identifications that passed the 5% FDR threshold. After running IDBoost, this number 
increased to 1348, augmenting sensitivity from 56% to 80%. Next, I evaluated the 
accuracy of rescued PSMs. A total of 1148 spectra (945 matched to synthetic sequences) 
were confidently identified in the original analysis, and 586 additional PSMs were 
rescued. As shown in Figure 10A, 69% of rescued spectra were correctly assigned to 
synthetic peptides with known PTM locations. Only 2% were false rescues that were 
originally assigned to the correct sequences, but then rescued to different ones. A close 
look at these false rescues revealed that they all were phosphorylation site isomers. The 
remaining 29% of rescued PSMs were associated with peptides that were not included in 
synthetic mixtures and thus are labeled “Unknown.”  
A sub-pie-chart in Figure 10A shows the proportion of top-ranked and secondary 
PSMs that were correctly rescued. 54% of rescued PSMs were correct top-ranked hits 
that failed to pass the FDR threshold. 10% correctly rescued PSMs were originally 
assigned wrong peptide sequences and 5% were assigned to phosphosite isomers. The 
result shows that both secondary phosphosite isomers and spurious random matches can 
be corrected through the rescuing process. 
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Figure 10. Analysis of rescued PSMs in phosphorylation studies. In each panel, the left 
pie chart shows the accuracy of rescued PSMs and the right sub-pie-chart represents a 
more detailed examination of correctly rescued PSMs. (A) Rescued PSMs from a 
synthetic phosphopeptide dataset. (2) Rescued PSMs from a phosphotyrosine enriched 
dataset. The result shows that IDBoost is able to recognize correct phosphosite isomers 
for rescue. 
 
  
This test established the “Bayesian average” method as an effective way to 
prioritize peptides in a cluster. Among 1678 spectra that were assigned correct sequences 
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within their top 5 PSMs, 70% contained phosphosite isomers, implying that a large 
number of spectra were mapped to multiple closely scored isomers during the rescuing 
process. The result indicates that the “Bayesian average” method is able to score correct 
sequences better than their phosphosite isomers, enabling rescue of these correct 
sequences rather than their isomers. Moreover, the result can be applied to resolve the 
ambiguous phosphosite localization. If a phosphosite isomer is rescued, it implies that 
this phosphorylation site is better supported than the original assignment by a cluster of 
similar spectra. In addition, this test illustrated that IDBoost is effective, even in datasets 
that contain a single analysis of each sample and where the MS/MS analyses employed 
dynamic exclusion to reduce repeated sampling of each peptide. 
It should be noted that in complex biological samples a single peptide may be 
singly phosphorylated at multiple locations, i.e., multiple positions all may be correct 
identifications. If similar spectra are produced by these isomers, the one with stronger 
identification evidence (better database search scores or more votes) may be scored 
superior to the correct position, thus rescuing a false positioning. Most likely this happens 
with phosphopeptides that produce similar fragment ions. In this case, IDBoost provides 
alternative interpretations for further manual validation. 
Next, I tested IDBoost performance using a real-world biological sample. The Jim 
Ayers Institute at Vanderbilt University collected three technical replicate runs of a 
human epithelial carcinoma cell lysate after enriching phosphotyrosine peptides with 
4G10 antibodies. The samples were analyzed on a Thermo Fisher LTQ Velos mass 
spectrometer. After MyriMatch and IDPicker analysis, 3327 spectra were confidently 
identified, counting all spectra without regard to phosphorylation status.  In this test, 1050 
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PSMs were added via IDBoost. The number of spectra assigned to phosphotyrosine 
peptides before and after running IDBoost was 1967 and 2512, respectively (a 28% 
increase).  
To estimate the accuracy of rescued PSMs, I considered a PSM as being rescued 
properly if its peptide contained a phosphotyrosine modification. In converse, PSMs that 
contained phosphotyrosine in original assignments, but which were rescued to non-
phosphotyrosine peptides were treated as false rescues. As shown in Figure 10B, 80% of 
rescued PSMs were proper rescues and 2% were false. The other 18% of PSMs that did 
not fall into these two categories were labeled “Unknown.” A close examination of the 
proper rescues showed 46% of rescued PSMs were top-ranked. 17% of spectra were 
rescued to secondary PSMs that were phosphosite isomers of top-ranked peptides. 17% 
of spectra were assigned different peptide sequences in the original analysis and were 
rescued to phosphotyrosine peptides. The result indicates that a large number of spectra 
assigned to phosphotyrosine peptides can be rescued. In addition, ambiguous 
phosphosites can be further evaluated in the context of a cluster of similar spectra. 
Bayesian average scores assigned to phosphosite isomers imply which phosphosite is 
better supported by these spectra than the other.  
 
II.4.2 Rescue of Spectra in Comparative Analysis 
In spectral count-based comparative analysis, differentially expressed proteins are 
determined by comparing the number of spectra observed for these proteins between 
pairs of cohorts. Generally, a larger average count difference yields a more significant 
result in statistical testing. To test if IDBoost helps to enhance spectral count 
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differentiation, I used a standardized dataset from the National Cancer Institute Clinical 
Proteomic Technologies Assessment for Cancer (CPTAC) Study 6 (Paulovich et al. 
2010), in which a mixture of 48 human proteins (Sigma UPS1, Sigma-Aldrich, St. Louis, 
MO) was spiked into the yeast reference proteome at different concentrations: A: 0.24, B: 
0.67, C: 2.54, D: 6.7, E: 20 fmol/µl and no spikes. After MyriMatch database search, five 
IDPicker analyses were performed to compare proteins between each concentration group 
and yeast sample that has no spikes (i.e., group A vs. yeast, group B vs. yeast etc.). I 
calculated the spectral count difference for each protein between yeast sample and the 
sample spiked with human proteins. The average differences for 48 spiked proteins and 
background proteins were compared before and after running IDBoost. In the presence of 
high concentrations of spiked proteins, the average differences for those proteins were 
much larger than for background proteins (see Figure 11, groups D and E), while the 
differences became less distinguishable for samples with low concentration spikes (see 
Figure 11, groups A and B). For all groups, IDBoost enlarged the spectral count 
differences for spiked proteins, with marginal effects on background proteins. Since these 
differences are the fundamental evidence for most statistical tests to determine 
differentially expressed proteins, running IDBoost improves sensitivity in differential 
proteomics by allowing the spiked proteins to be better recognized.  
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Figure 11. Impact of IDBoost on recognition of differentially expressed proteins in 
comparative analysis. 48 human proteins were spiked into a yeast proteome with 
decreased concentrations from group E to A. The spectral count differences between two 
samples, yeast and yeast with spikes, were calculated for each protein. Here I examine 
the average number of differences for two groups of proteins, 48 spiked proteins (SK) 
and the background yeast proteins (BG). The numbers of identified proteins are enclosed 
in parentheses. In all tests, IDBoost enhances the spectral count differences of 
differentially expressed proteins (spiked proteins) in comparative analysis. 
 
This method is particularly valuable for samples with low concentration of 
differentially expressed proteins. In Figure 11, for example, fewer spiked proteins were 
identified as their concentrations decreased. The high concentration samples E and D 
may benefit less from IDBoost due to the fact that the spectral count differences for 
spiked proteins were already much larger than background proteins. However, the 
comparative analysis may be improved by the use of IDBoost for sample C and B in 
which the differences of spiked proteins were close to those of background proteins. In 
these cases, by increasing the spectral count differences for spiked proteins, IDBoost 
allows the spiked proteins being selected more confidently in statistical analysis. Sample 
A was intentionally spiked with too low a concentration for most differences to be 
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observed. Only 2 of 48 spiked proteins were identified, and no differences were found 
between experiments. 
 
II.4.3 Rescue of Spectra in a Variety of Datasets 
I first tested IDBoost performance using two sample mixtures collected for 
CPTAC Study 6 (Paulovich et al. 2010). The Sigma UPS1 sample (Sigma-Aldrich, St. 
Louis, MO) is a defined mixture that contains 48 human proteins in equimolar 
concentrations. The yeast sample is a protein extract of Saccharomyces cerevisiae, 
representing a highly complex biological proteome. Both samples were prepared by the 
NIST and shipped to the CPTAC sites. I selected nine files for each sample (triplicates 
from three instruments) collected from two instrument platforms: a high resolution 
Thermo Fisher LTQ-Orbitrap and a lower resolution LTQ linear ion trap mass 
spectrometer. All spectra were searched using MyriMatch and post-processed by 
IDPicker. For each sample, I ran IDBoost against either all nine files collected from an 
instrument type or within the three files collected from a particular instrument.  
Figure 12 shows the number of spectral identifications before and after running 
IDBoost, along with the percent of gained spectra in each analysis. This figure 
demonstrated IDBoost performance in a variety of sample complexities and 
instrumentation. First, simple mixtures (UPS1) benefit more from the rescue process than 
do complex samples (yeast). The percent of gained spectra varied from 17% to 52% for 
the UPS1 sample, and these gains were always higher than for yeast (below 15%). 
Second, data from low resolution instruments tend to gain more identifications than those 
from high resolution instruments. In both UPS1 and yeast samples, the proportions of 
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rescued spectra were higher in LTQ data than those in Orbitrap runs, probably because 
the high resolution data yielding more confident IDs in MyriMatch search, leaving fewer 
spectra for rescue. Third, IDBoost shows enhanced performance for datasets with more 
replicates, even when they come from different instruments. Processing all files together 
yielded more rescued spectra than processing each instrument set separately.  
In terms of running time, IDBoost spent around 1 minute to process each set of 
triplicates from an individual instrument for UPS1 data and 2 minutes for yeast data on a 
Dell Optiplex 745 computer with an Intel Core 2 Duo 6400 processor and 3 GB of RAM. 
When processing all nine files together, IDBoost spent 6 minutes on UPS1 LTQ data and 
2 minutes on UPS1 Orbi data. It took about 8 minutes to process all nine files for yeast 
LTQ and Orbi data. 
I also tested IDBoost on a large-scale study using MudPIT technology (Arnett et 
al. 2008). 63195 of 337602 spectra were identified by MyriMatch and IDPicker analysis. 
After running IDBoost, the spectral identifications increased 26% to 79709. IDBoost 
spent 24 minutes to process all 116 files conjointly. 
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Figure 12. IDBoost performance in a variety of datasets. UPS1 (A) and yeast (B) samples, 
each with three technical replicates, were analyzed on three individual instruments in two 
instrument platforms. Search results from either each instrument (3 files) or all 9 files 
from an instrument platform were processed using IDBoost. The number of spectra 
before and after running IDBoost is presented. The proportion of gained spectra is 
reported for each analysis. 
 
II.5 Conclusion 
I presented a method to rescue spectral identifications and correct database search 
errors through spectral clustering. I demonstrated the use of IDBoost in phosphorylation 
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studies and comparative analysis. I tested the effectiveness of IDBoost in a variety of 
datasets. Experiments with many replicates and low accuracy data tend to benefit most 
from the use of IDBoost. IDBoost provides an easy and fast way to expand confident 
spectral identifications based on existing analysis with no requirement of additional 
identification steps. Its use is not limited to particular search engines or post-processing 
tools and thus it can be integrated into established proteomics data analysis workflows. 
The IDPicker GUI in which IDBoost is embedded enables visualization and manual 
validation of rescued identifications. 
To cluster similar spectra, IDBoost computes a dot product for each pair of 
spectra. This method has been proved to be effective in most cases but is highly affected 
by major peaks. In the future, more robust methods such as the scoring system in 
Pepitome can be implemented to replace the dot product for spectra similarity 
comparison.   
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CHAPTER III 
 
SCANRANKER: QUALITY ASSESSMENT OF TANDEM MASS SPECTRA VIA 
SEQUENCE TAGGING  
 
III.1 Introduction 
A large number of high quality spectra remain unidentified after database search 
due to modifications, incompleteness of protein databases, constrained search parameters 
and the deficiencies of the scoring methods in database search tools. These spectra often 
represent meaningful biological information and are potentially identifiable with 
alternative approaches such as blind modification search and de novo sequencing (Ning et 
al. 2010). An automated spectral quality assessment tool helps to ameliorate these 
problems. It can be used to find unidentified high quality spectra for subsequent analysis 
and helps to select high quality spectra for de novo sequencing.  
Mass spectrometry has become a method of choice to characterize cross-linked 
proteins (Leitner et al. 2010). The identification of cross-linked peptides, however, is 
quite a daunting job due to the overwhelming number of possible matches and the 
difficulty of interpreting spectra from cross-linked peptides. Although several 
bioinformatics tools have been developed to relieve theses difficulties, manual 
confirmation of cross-linked peptides is generally necessary. A spectral quality 
assessment tool could facilitate this process by providing a ranked list of spectra for 
manual interpretation.  
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The spectral quality score can also be used in the process of peptide assignment 
validation. In database search, software tools usually assign different scores to measure 
the match between spectrum and peptide (e.g., XCorr from Sequest and IonScore from 
Mascot), which are subsequently used in statistical analysis to estimate FDR. The spectral 
quality score could become an additional score in this process, because high quality 
spectra are more likely to produce confident peptide identifications.  
The scoring methods in sequence tagging algorithms are applicable for quality 
assessment of tandem mass spectra. A high quality spectrum of a peptide is expected to 
contain a series of consecutive fragment ions corresponding to peptide bond breakages 
(Tabb et al. 2006). These fragments provide a basis for partial sequence inference that 
result in multiple tags with good scores. Conversely, if no sequence tags can be inferred 
from a spectrum, it is unlikely that the spectrum will produce a high score in database 
search. Sequence tagging is a robust approach for spectral quality assessment because 
even modified or mutated peptides can produce consecutive fragment ions. Recently, we 
developed a novel sequence tagging algorithm, DirecTag (Tabb et al. 2008), which 
demonstrated superior accuracy in comparison to existing sequence tagging tools. In this 
work, I explore the use of DirecTag along with other metrics for spectral quality 
assessment. 
Several spectral quality assessment tools have been developed in recent years. 
Pioneering work by Bern et al. (2004) predicted spectral quality based on a set of 
handcrafted features  Other studies by Xu et al. (2005) as well as by Salmi et al. (2006) 
reported a quadratic discriminant function and a random forest classifier to separate good 
and bad spectra, respectively. Na & Paek (2006) proposed a cumulative intensity 
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normalization method for quality assessment, while Flikka et al. (2006) tested several 
machine learning classifiers in data from three different mass spectrometers, recognizing 
that the performance of classifiers is greatly affected by the type of instrument. More 
recently, Nesvizhskii et al. (2006) developed QualScore, which produces accurate results 
to find unassigned good spectra after database search. In these prior studies, the proposed 
methods were usually evaluated based on their performance in removing low quality 
spectra and recovering unassigned high quality spectra. In fact, quality assessment tools 
are useful for a wide variety of applications that have not previously been demonstrated. 
These tools may help to prioritize spectra for de novo sequencing and cross-linking 
analysis, which are usually very time-consuming processes relying heavily on manual 
inspection. Besides, since high quality spectra are more likely to produce confident 
identifications in database search, the quality assessment tools can also be used for 
quality control of datasets in large-scale proteomic studies. 
In this work, I present ScanRanker, a new software tool that evaluates spectral 
quality via sequence tagging. I evaluate ScanRanker using a variety of datasets from 
multiple instrument platforms with different sample complexities. I demonstrate that 
ScanRanker can be used both to recognize high quality spectra that fail identification and 
to remove low quality spectra prior to database search. In addition, I demonstrate several 
applications of spectral quality score that are not explored in existing publications. I show 
that ScanRanker scores can be used to predict the richness of identifiable spectra among 
LC-MS/MS runs in an experiment. I demonstrate the use of ScanRanker scores in the 
process of peptide assignment validation. I also demonstrate that ScanRanker helps to 
select high quality spectra for de novo sequencing and cross-linking analysis.  
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III.2 Algorithm 
III.2.1 Overview 
ScanRanker makes use of the DirecTag algorithm to infer sequence tags from 
tandem mass spectra. It then computes a quality score for each spectrum on the basis of 
three tag-based scoring metrics: “BestTagScore”, “BestTagTIC” and “TagMzRange”. 
ScanRanker accepts spectra in mzML, mzXML and MGF file formats via use of the 
ProteoWizard library. Several proprietary formats, such as Thermo RAW files and 
Bruker YEP files, can also be directly processed with no required installation of vendor-
supplied software libraries (a detailed list of supported formats is available at 
http://proteowizard.sourceforge.net/docs.html). ScanRanker can be executed in both 
Microsoft Windows and Linux systems, though native support for vendor formats 
requires use of Windows. A GUI was created in C#/.NET for Windows users. A helper 
program, IonMatcher, was also developed to visualize ScanRanker results and enable 
interactive manual inspection of peptide-spectrum matches. The source code and 
executable versions of ScanRanker are available from http://fenchurch.mc.vanderbilt.edu. 
The screenshot of the ScanRanker GUI is shown in Figure 13. The ScanRanker 
GUI contains three major parts: "Spectral Quality Assessment", "Spectral Removal" and 
"Spectral Recovery". The "Spectral Quality Assessment" feature controls parameters for 
running sequence tagging by DirecTag. It writes out a metrics file, which can be used 
later for "Spectral Removal" and “Spectral Recovery”. If the charge state of a spectrum is 
not determined (for example, LTQ data), a spectral quality score will be assessed for each 
charge state, and the highest quality score will be retained.  
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Figure 13. A screenshot of ScanRanker GUI.  
 
 
The “Spectral Removal” feature generates a subset of high quality spectra in 
mzML, mzXML, MGF or MS2 format, which can be used for more intensive searches. 
The "Spectral Recovery" feature makes use of "idpQonvert" module in IDPicker software 
to determine which spectra are identified. Based on the idpQonvert result, it adds a label 
(1 or 0) to each spectrum in a metrics file to indicate whether the spectrum is identified 
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by IDPicker. The corresponding peptides and proteins of identified spectra will also be 
included in the metrics file. ScanRanker generates unidentified high quality spectra for 
further analysis such as de novo sequencing and cross-linking analysis. 
The screenshot of the IonMatcher GUI is shown in Figure 14. IonMatcher reads a 
spectrum file and a metrics file to allow manual inspection of spectral quality. More 
importantly, it enables interactive validation of peptide-spectrum matches. If a metrics 
file is generated by “Spectral Recovery”, the identified peptide sequence will be 
displayed in a data table. Clicking a row in the table brings up four panels: annotation 
panel, fragmentation panel, spectrum panel and de novo sequencing panel. The peptide 
sequence in annotation panel can be modified interactively to exam the match between a 
modified sequence and the spectrum. Cross-correlation scores are reported for each 
sequence. The fragmentation panel displays m/z values of selected fragment ion series in 
which matched ions are bold highlighted. The spectrum panel shows matched ions and 
fragmentation ladders.  
If no peptide was assigned to a spectrum in database search, potential 
interpretations of the spectrum can be inferred using PepNovo, a state-of-the-art de novo 
sequencing tool developed at University of California, San Diego (UCSD). Inferred 
peptide sequences can be copied to annotation panel for manual validation. It should be 
noted that PepNovo program is not included in the ScanRanker package. To enable the de 
novo sequencing function, please download PepNovo at 
http://proteomics.ucsd.edu/index.html and copy all files to the \ScanRanker-installation-
directory\PepNovo folder. Copyright and License information of PepNovo are available 
in UCSD website. 
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Figure 14. A screenshot of IonMatcher GUI.  
 
III.2.2 BestTagScore Subscore 
DirecTag evaluates sequence tags on the basis of peak intensity, m/z fidelity and 
complementarity. Each tag is assigned a p-value to represent the probability that a better 
score would have resulted by chance. Here I made use of the score of the top ranked tag 
as the “BestTagScore” subscore for spectral quality assessment. Spectra that are capable 
of generating high quality tags are more likely to be good spectra. 
 
III.2.3 BestTagTIC Subscore 
To infer sequence tags, DirecTag constructs a graph comprising nodes 
representing peaks and edges representing pairs of peaks that are separated by amino acid 
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masses. DirecTag seeks out consecutive edges in this graph to enumerate sequence tags. 
For example, a set of four connected nodes in the graph may constitute a tag of three 
amino acids. Each node in a spectrum graph is associated with a peak intensity value. The 
“BestTagTIC” subscore sums up peak intensities of the top ranked tag. A high quality 
spectrum is expected to have a higher “BestTagTIC” subscore than low quality ones in a 
dataset. Spectra that are higher in intensity are more likely to produce tags of high TIC. 
 
III.2.4 TagMzRange Subscore 
Each inferred tag corresponds directly to a series of fragments in a tandem mass 
spectrum. The “m/z range” of a tag is the m/z distance that extends from the first peak to 
the last peak of the tag. By examining all enumerated tags, the “TagMzRange” subscore 
describes the widest range of m/z values for a spectrum that is spanned by tags. For a 
spectrum generating many tags, the “TagMzRange” subscore is equal to the m/z range 
between the lowest m/z peak and the highest m/z peak across all enumerated tags minus 
any m/z areas that are not spanned by tags. If tags can be generated from a wide m/z range 
in a spectrum, it is more likely that this spectrum will be identifiable by computational 
tools. 
 
III.2.5 Spectral Quality Score 
Three subscores are subjected to logarithmic transformation and normalized 
before generating a final quality score. The normalization of each subscore is performed 
by subtracting the mean of subscores in that dataset, and then divided by the interquartile 
range of these subscores. Spectra with no inferred tags or the best scored tags exceeded 
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the threshold specified in configuration file, usually 10-20% of spectra in a dataset, are 
considered as low quality spectra and are excluded in the calculation of mean and 
interquartile range. ScanRanker computes the average of three normalized subscores as 
the final quality score. Multiple LC-MS/MS runs, such as MudPIT or gel band runs, can 
be optionally grouped together as a single experiment, for which the mean and 
interquartile range of subscores across all datasets will be used for normalization. 
During developing the scoring method, I also attempted to use logistic regression 
and support vector machine based models to generate quality scores. These models can 
handle a large number of variables, so other attributes such as the number of peaks in a 
spectrum, total ion intensity and the ratio of strong and weak peaks in a spectrum can be 
incorporated into the scoring system. However, I found the proposed method with three 
variables can achieve almost the same performance as using more variables in 
sophisticated models. Therefore, only three most discriminating features were retained 
for quality assessment here. 
 
III.3 Data Sources 
The evaluation of the ScanRanker algorithm employed several datasets collected 
from different instrument platforms (see Table 3). The configurations of ScanRanker and 
other software tools are given in Appendix A. Instrument raw files were converted to 
mzXML format using the MSConvert tool of the ProteoWizard library. DTA format files 
required for Sequest search were extracted from the mzXML files using mzxml2search 
program of Trans-Proteomic Pipeline (Institute of Systems Biology, Seattle, WA) (Keller 
et al. 2005). In database search, common contaminant proteins were added to protein 
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databases, and reversed versions of all sequences were appended as decoy sequences for 
FDR estimation. The database search results were processed by IDPicker software for 
peptide validation and protein assembly. Throughout this study, IDPicker was configured 
to derive score thresholds to yield a 2% FDR. Peptides passing these thresholds were 
considered as legitimate identifications. Spectra for which these peptides were assigned 
were considered as “identified spectra”. The datasets are available for download from 
Vanderbilt University Mass Spectrometry Research Center’s web site 
(http://www.mc.vanderbilt.edu/msrc/bioinformatics/data.php).  
 
“DLD1 LTQ” Dataset 
This dataset was previously used to test IDPicker software and the experimental 
description was published by Ma et al. (2009). The “DLD1 LTQ” dataset consisted of 
four RPLC runs of human colon adenocarcinoma cells (DLD-1 cell line) analyzed on a 
Thermo Fisher LTQ linear ion trap mass spectrometer (San Jose, CA). The files averaged 
12,913 MS/MS scans. Spectra were identified against an IPI human database (v3.56) 
using database search engines MyriMatch. Sequest and X!Tandem search results were 
converted to pepXML format using out2xml and tandem2xml programs in the Trans-
Proteomic Pipeline, respectively. Raw peptide identifications were processed by the 
IDPicker software for protein assembly. Spectra were classified into two categories, 
“identified spectra” and “unidentified spectra”, where the identified set pooled data from 
all three database searches. 
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Dataset name 
# of 
files 
(Average) # of 
MS/MS scans Identification methods Databases used for search 
Removal of Low Quality Spectra 
DLD1 LTQ 4 12913 
MyriMatch, Sequest, 
X!Tandem IPI.HUMAN.v3.56  
Mouse HCT 4 5408 
MyriMatch, Sequest, 
X!Tandem IPI.MOUSE.v3.62 
Yeast Velos 5 38466 
MyriMatch, Sequest, 
X!Tandem SGD.orf_trans_all.20090303 
Recovery of Unidentified High Quality Spectra 
DLD1 LTQ 1 12820 
Sequest/MyriMatch, 
X!Tandem IPI.HUMAN.v3.56  
Serum Orbi 1 6697 
MyriMatch, 
tryptic/semi-tryptic IPI.HUMAN.v3.56  
Histone Orbi 1 9170 MyriMatch/TagRecon IPI.HUMAN.v3.68 
Prediction of Richness of Identifiable Spectra 
MudPIT Orbi 10 9828 MyriMatch IPI.HUMAN.v3.56  
IEF Orbi 10 10897 MyriMatch IPI.HUMAN.v3.56  
GelBand 
LTQ 10 9520 MyriMatch IPI.HUMAN.v3.47 
Use of Quality Score in Peptide Validation 
DLD1 LTQ 4 12913 
Mascot, Sequest, 
X!Tandem IPI.HUMAN.v3.56  
Selection of Spectra for De Novo Sequencing 
Yeast Velos 1 38560 PepNovo, MyriMatch SGD.orf_trans_all.20090303 
Tardigrade 
QSTAR 1 837 PepNovo, MyriMatch 
SwissProt.DROME.ANOGA.C
AEEL.rel56.8 
Hadrosaur 
Orbi 1 14217 PepNovo, MyriMatch AnoCar1.0 
Use of ScanRanker in Cross-linking Analysis 
Crosslink 
Orbi 1 1161 Protein Prospector SwissProt.ECOLI.20100810 
 
Table 3. Experimental datasets for the evaluation of ScanRanker.  
 
“Serum Orbi” Dataset 
This dataset was previously used to test IDPicker software and the experimental 
description was published by Ma et al. (2009). The “Serum Orbi” data represented an 
RPLC analysis of depleted human serum sample in an LTQ-Orbitrap hybrid mass 
spectrometer (Thermo, Scan Jose, CA) at Vanderbilt University Medical Center. Spectra 
were identified against an IPI Human database (v3.56) using MyriMatch in either tryptic 
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or semi-tryptic search mode. Search results were processed by IDPicker and spectra were 
separated to three categories: “spectra identified in tryptic search”, “new identifications in 
semi-tryptic search” and “unidentified spectra”. 
 
“Histone Orbi” Dataset 
This dataset was published by Loecken et al. (2009). Histone H2b and H3 adducts 
was analyzed using an LTQ-Orbitrap mass spectrometer. Spectra were searched using 
MyriMatch against an IPI human database (v3.68) and processed by IDPicker for peptide 
validation and protein assembly. The identified proteins were pulled to construct a subset 
protein database for bind modification search by TagRecon.  
 
“MudPIT Orbi” Dataset 
This dataset was published by Slebos et al. (2008).  Tryptic peptides from 50 µg 
proteins (adenocarcinoma) were loaded to a SCX column followed by a reverse phase 
LC-MS/MS analyses. Spectra from 10 fractions in the MudPIT experiment were searched 
using MyriMatch against an IPI Human database (v3.56) and processed by IDPicker. 
 
“IEF Orbi” Dataset 
This dataset was published by Slebos et al. (2008). Tryptic peptides from 50 µg 
proteins (adenocarcinoma) were separated by isoelectric focusing, followed by a reverse 
phase LC-MS/MS analyses. Spectra from 10 fractions in the IEF experiment were 
searched using MyriMatch against an IPI Human database (v3.56) and processed by 
IDPicker. 
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“GelBand LTQ” Dataset 
This dataset was published by Burgess et al. (2008). Serum samples were 
collected from patients without evidence of malignancy. Alpha 2 macroglobulin-
containing protein complexes were immunoprecipitated and separated by molecular 
weight in 10% SDS-PAGE. Each lane was sliced into 10 regions and subjected to in-gel 
digestion. Peptides from each gel region of each patient were subjected to a 95 minute 
RPLC separation. As peptides eluted in nanospray, the ions were directed to the inlet of a 
Thermo LTQ tandem mass spectrometer. Spectra were searched using MyriMatch against 
an IPI Human database (v3.47) and processed by IDPicker. 
 
“Tardigrade QSTAR” Dataset 
Hypsibius dujardini, a species of Tardigrades (commonly known as 'water bears') 
were grown in glass Petri dishes feeding on algae.  Proteins from 600 organisms were 
collected and solubilized in LDS buffer (1M DTT), boiled, sonicated and then separated 
by 1D SDS-PAGE. Contiguous gel bands were excised, digested (trypsin), and samples 
were analyzed by reverse-phase nano-HPLC-ESI-MS/MS using an Eksigent nano-LC 2D 
HPLC system (Eksigent, Dublin, CA) which was directly connected to a quadrupole 
time-of-flight (QqTOF) QSTAR Elite mass spectrometer (MDS SCIEX, Concorde, 
CAN). Briefly, peptide mixtures were loaded onto a guard column (C18 Acclaim 
PepMap100, 300 µm I.D. x 5 mm, 5 µm particle size, 100 Å pore size, Dionex, 
Sunnyvale, CA) and washed with the loading solvent (0.1 % formic acid, flow rate: 20 
µL/min) for 5 min. Subsequently, samples were transferred onto the analytical C18-
nanocapillary HPLC column (C18 Acclaim PepMap100, 300 µm I.D. x 15 cm, 3 µm 
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particle size, 100 Å pore size, Dionex, Sunnyvale, CA) and eluted at a flow rate of 300 
nL/min using the following gradient:  2-40% solvent B in A (from 0-35 min), 40-80% 
solvent B in A (from 35-45 min) and at 80% solvent B in A (from 45-55 min), with a 
total runtime of 85 min (including mobile phase equilibration). Solvents were prepared as 
follows, mobile phase A: 2% acetonitrile / 98% of 0.1% formic acid (v/v) in water, and 
mobile phase B: 98% acetonitrile / 2% of 0.1% formic acid (v/v) in water. Mass spectra 
(ESI-MS) and tandem mass spectra (ESI-MS/MS) were recorded in positive-ion mode 
with a resolution of 12000-15000 full-width half-maximum. For collision induced 
dissociation tandem mass spectrometry (CID-MS/MS), the mass window for precursor 
ion selection of the quadrupole mass analyzer was set to ± 1 m/z. The precursor ions were 
fragmented in a collision cell using nitrogen as the collision gas. Advanced information 
dependent acquisition (IDA) was used for MS/MS collection, including QSTAR Elite 
(Analyst QS 2.0) specific features, such as “Smart Collision” and “Smart Exit” (fragment 
intensity multiplier set to 4.0 and maximum accumulation time at 2.5 sec) to obtain 
MS/MS spectra for the three most abundant parent ions following each survey scan.  
Dynamic exclusion features were based on value M not m/z and were set to exclusion 
mass width 50 mDa and exclusion duration of 120 sec. Since complete genomic 
sequences for tardigrade are not yet available, I searched the dataset using MyriMatch 
against a database consisting of proteins from three taxonomically related species with 
complete proteomes, Drosophila melanogaster (DROME), Anopheles gambiae (African 
malaria mosquito, ANOGA) and Caenorhabditis elegans (CAEEL), downloaded from 
Swiss-Prot (release 56.8). Reversed sequences of these proteins were appended to the 
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database as decoys. Spectra were separately processed by PepNovo for de novo 
sequencing and ScanRanker for spectral quality assessment. 
 
“Hadrosaur Orbi” Dataset 
This “Hadrosaur Orbi” dataset represented an RPLC run of protein extracts from 
an 80-million-year-old Campanian hadrosaur, Brachylophosaurus canadensis, in a 
Thermo Fisher LTQ Orbitrap XL mass spectrometer published by Asara et al. 
(Schweitzer et al. 2009). The mzData file was downloaded from PRIDE 
(http://www.ebi.ac.uk/pride/, accession number 9285) and was converted to mzXML 
format using a predecessor of the MSConvert tool from the ProteoWizard library, which 
was subsequently processed by PepNovo and ScanRanker. Spectra were searched using 
MyriMatch against a lizard (Anolis carolinensis) database, AnoCar1.0, produced by the 
Broad Institute at MIT and Harvard (http://www.broadinstitute.org/models/anole). 
Common contaminant proteins were added to supplement these sequences, and reversed 
versions of all sequences were appended to complete the FASTA. 
 
“Crosslink Orbi” Dataset 
This dataset was provided by Robert Chalkley at University of California, San 
Francisco and published by Trnka, M. J. et al. (Trnka & Burlingame 2010). Purified 
GroEL and GroES proteins were cross-linked by 1,3-diformyl-5-ethynylbenzene (DEB).  
The sample was analyzed on an ESI LTQ-OrbitrapXL with an ETD module installed 
(Thermo Scientific). Cross-linked spectra were identified using Protein Prospector and 
were manually confirmed by Trnka et al. The dataset was also searched using Protein 
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Prospector against SwissProt E.coli database to identify spectra of non-crosslinked 
peptides. The search were performed with both parent and product mass tolerance of 20 
ppm. Carbamidomethylcysteine was searched as a fixed modification. Methionine 
oxidation, protein N-terminal acetylation and peptide N-terminal glutamine cyclization to 
pyroglutamate were specified as variable modification.  
 
“Mouse HCT” Dataset 
This dataset was generated from a whole mouse liver protein extract obtained 
from adult CD1 mice in Vanderbilt University Mass Spectrometry Research Center. 
Proteins were reduced with DTE and alkylated with iodoacetamide prior to digestion with 
sequencing grade Trypsin.  Four replicate LC-MS/MS runs were performed on a Bruker 
Esquire HCT ultra ion trap (Bruker Daltonics, Billerica, MA). The scan sequence 
consisted of 1 precursor ion scan (m/z = 375-1200) in standard enhanced and five 
subsequent tandem MS scans (m/z = 100-2800) in ultra scan mode.  Scan averaging was 
set to 2 and ICC was 200,000. Singly charged peptides were excluded from tandem MS 
and dynamic exclusion was activated for 1 minute after two successful tandem MS 
experiments for a peptide.  LC-MS/MS was carried out on an Agilent 1100 HPLC 
modified with a flow splitter and a FAMOS autosampler with a 2 µl sample loop. The 
column was a 12.5 cm, singly-vented, 360/75 um OD/ID PicoFrit emitter from New 
Objective attached to a 3 cm precolumn. Both columns were packed in house with 5 µm 
Monitor C18 particles. Each injection consisted of 6.5 ng of mouse liver digest. The 
mobile phases were water and acetonitrile with 0.1 % formic acid as an additive. Peptides 
eluted during the 60 minute gradient from 2 % to 50 % acetonitrile. Instrument raw data 
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were converted to mzXML format using the Bruker CompassXport tool. The files 
averaged 5048 MS/MS scans. Spectra were searched against an IPI mouse database 
(v3.62) by MyriMatch, Sequest and X!Tandem and processed as described in the “DLD1 
LTQ” dataset. 
 
“Yeast Velos” Dataset 
This dataset was generated utilizing the CPTAC Yeast Performance Standard that 
was digested with trypsin in Rapigest (Paulovich et al. 2010). Two microliter portions of 
peptide mixture were analyzed using a Velos ion trap mass spectrometer (Thermo, San 
Jose, CA) equipped with an Eksigent 1D Plus NanoLC pump and Eksigent NanoLC-AS1 
autosampler (Eksigent, Dublin, CA). Peptides were solid-phase extracted using an in-line 
column (100 µm × 6 cm) packed with Jupiter C18resin (5 µm, 300 Å, Phenomenex, 
Torrence, CA) and separated on a capillary tip (100 µm × 11 cm, Polymicro 
Technologies, Phoenix, AZ) packed with the C18 resin.  Following the injection, peptides 
were solid-phase extracted by washing with 0.1% FA (mobile phase A) for 15 min at a 
flow rate of 1.5 µL/min.  Mobile phase B consisted of acetonitrile (ACN) with 0.1% FA.  
Peptides were separated using a gradient of 2−40% B for 120 min at a flow rate of 700 
nL/min, followed by a rapid increase of B from 40−90% in 25 min, and held at 90% B 
for 9 min before returning to initial conditions of 100% A. Survey scans were collected in 
the ion trap a mass range of 400−2000 m/z. Following each survey scan, the five most 
intense ions were selected for MS/MS fragmentation in the ion trap using the dynamic 
exclusion feature (exclusion mass width of -1 m/z and +2 m/z, exclusion duration of 60 s, 
and repeat count of 1). Centroided MS/MS scans were acquired on the Velos using an 
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isolation width of 2 m/z, an activation time of 30 ms, an activation q of 0.250 and a 
normalized collision energy of 30 using 1 microscan with a max ion time of 100 ms for 
each MS/MS scan and 1 microscan with a max ion time of 50 ms for each full MS scan 
and a minimum signal of 1000.  The mass spectrometer was tuned prior to analysis using 
the synthetic peptide TpepK (AVAGKAGAR), and the tune parameters were as follows: 
spray voltage of 1.5 kV, a capillary temperature of 200 °C and an S-lens RF level of 59%. 
The MS/MS spectra were collected using data-dependent scanning in which one full MS 
spectrum was followed by four MS-MS spectra. MS/MS spectra were recorded using 
dynamic exclusion of previously analyzed precursors for 60 s with a repeat count of 1 
and a repeat duration of 1. A total of five replicate LC-MS/MS experiments were 
performed and 192,330 MS/MS spectra were collected. Spectra were searched using 
MyriMatch, Sequest and X!Tandem against the Saccharomyces Genome Database 
orf_trans_all.fasta file downloaded in March of 2009 and processed by IDPicker. 
 
III.4 Results and Discussion 
To establish the effectiveness of ScanRanker in quality estimation, I first 
evaluated its three metrics for discrimination. After establishing its scoring discrimination, 
I tested its real-world performance for recognition of unidentified high quality spectra 
and prediction of richness of identifiable spectra. I also demonstrated its applications in 
peptide validation, de novo sequencing and cross-linking analysis. These tests establish 
ScanRanker as a robust and effective algorithm for spectral quality assessment of data 
from various instruments in a wide variety of applications. 
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III.4.1 Subscore Evaluation 
ScanRanker evaluates spectral quality based on “BestTagScore”, “BestTagTIC” 
and “TagMzRange” subscores. To test the effectiveness of subscores, the “DLD1 LTQ” 
(Ma et al. 2009) dataset was searched by MyriMatch, Sequest and X!Tandem to 
maximize the peptide identifications. The discriminating power of each subscore is 
illustrated via receiver operating characteristic (ROC) curves in Figure 15. Each subscore 
may be used to discriminate spectral quality between identified and unidentified spectra. 
By combining the three subscores, however, ScanRanker achieves better discrimination 
than by using any single subscore alone. Results obtained after testing any combination 
of two subscores were exceeded by combining all three subscores (data not shown). 
 
 
Figure 15. Combining three subscores improves the discriminating power of ScanRanker. 
Tests on the “DLD1 LTQ” dataset revealed different discrimination in ScanRanker’s 
subscores. The ROC curves display true positive rate (a.k.a. sensitivity) and false positive 
rate (a.k.a. 1-specificity) of ScanRanker’s subscores and the combined score. The AUC 
values show that combining three subscores yields better discrimination than using any 
single subscore.  
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I tested both mean and median for subscore normalization during the development 
of ScanRanker algorithm, and they worked equally well because of small differences 
between these values. For example, the average difference between mean and median of 
“DLD1 LTQ” dataset (4 replicates) are 1%, 6% and 2% for “BestTagScore”, 
“BestTagTIC” and “TagMzRange” subscores, respectively. I chose the mean of 
subscores for normalization because it is less expensive to compute than the median. 
More importantly, if ScanRanker scores need to be adjusted across multiple files, the 
mean of subscores across these files can be easily calculated based on the sum of 
subscores and the total count of spectra.  
ScanRanker computes the quality score by averaging three normalized subscores. 
If the subscores differed considerably in their discriminating powers, simply averaging 
the subscores would reduce the discriminating power of ScanRanker overall. To test the 
discrimination difference between optimized score weights and equal weights, each 
subscore was assigned a weight from 0 to 1 with 0.1 increments, and the summation of 
weighted subscores was used to calculate the area under ROC curve (AUC). The best 
possible weighting yielded an AUC less than 1% higher than the equal weight approach. 
As a result, I opted to use equal weights for simplicity. 
 
III.4.2 Removal of Low Quality Spectra 
Low quality spectra, particularly from ion trap mass spectrometers, often generate 
a significant amount of computational overhead but contribute little to protein 
identification. Filtering these spectra via ScanRanker prior to search can save time in 
identification. To test ScanRanker’s performance in removing low quality spectra, I 
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analyzed three datasets collected from a Thermo Fisher LTQ, an Esquire HCT ultra and a 
Thermo Fisher LTQ Velos ion trap. MyriMatch searched these data in two ways: (1) 
search all spectra, (2) only search the top 60% of high quality spectra as reported by 
ScanRanker. In all three instruments, more than 94% of the resulting identifications were 
shared between both searches, and more spectra were identified in the second search than 
in the first. In the case of the Esquire HCT, almost 5% of the identifications were 
produced only when the bottom 40% of spectra were pruned away, at the cost of less than 
1% of the identifications (see Figure 16). More identifications were gained by removing 
low quality spectra prior to database search; low quality spectra are more prone to be 
matched to decoy sequences, thus increasing the stringency of the threshold applied to all 
identifications. 
 
 
Peptide 
Spectrum 
(A) 
(D) 
(B) 
(E) 
(C) 
(F) 
DLD1 LTQ 
All spectra
  
High quality 
spectra 
Mouse HCT 
All spectra High quality 
spectra 
Yeast Velos 
All spectra High quality 
spectra 
98.1% 1.1% 0.8% 
98.5% 0.9% 0.6% 
94.4% 4.9% 0.7% 
93.1% 5.9% 1.0% 
98.1% 1.2% 0.7% 
97.9% 1.3% 0.8% 
 
 
Figure 16. Removing poor MS/MS scans in ScanRanker does not significantly reduce 
identifications. Panels A-C show the percent overlap of identified spectra when searching 
either all spectra or only high quality spectra. Similar overlaps for identified peptides are 
displayed in Panels D-F.  
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Although I retained the top 60% spectra in our test, it should be noted that there is 
no common threshold that can be applied to all datasets for the selection of high quality 
spectra. The spectral removal will be more beneficial for large-scale proteomics studies 
in which multiple biological and technical replicates are analyzed. I recommend 
determining the percentage of retained spectra by examining the search results of all 
spectra from a single replicate, then applying the threshold to remove low quality spectra 
in other replicates. For example, Figure 17 plots the proportion of retained identified 
spectra in context of spectra sorted by ScanRanker scores. It is obvious that the top 
ranked 60% spectra in all three datasets contain more than 95% of identified spectra. 
Therefore, this threshold could be subsequently used to remove low quality spectra in 
other replicates before the database search. These figures can be easily generated from 
ScanRanker output, which comprises a tab-delimited text file including ranked spectra, 
identification labels and the cumulative sum of identification labels. 
 
 
 
Figure 17. Determine spectral removal threshold from a single replicate.  
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III.4.3 Recovery of Unidentified High Quality Spectra 
Simple database search can sometimes fail to identify many spectra that can be 
identified through additional effort. I employed three publicly available datasets to 
determine if ScanRanker scores were predictive of identifications gained through more 
advanced searching methods. 
In the first test, I evaluated the peptides identified through multiple database 
search algorithms. A single replicate in the “DLD1 LTQ” dataset with 12820 MS/MS 
scans was analyzed using Sequest, yielding 2878 confidently identified spectra. 
Additional searches using MyriMatch and X!Tandem identified 826 new spectra missed 
in the Sequest search. All spectra were sorted by ScanRanker scores from high to low 
quality and were split into deciles. Figure 18A shows the number of initially identified 
spectra, newly identified spectra and unidentified spectra in each decile. As expected, 
identified spectra, either by Sequest or additional searches, were associated with higher 
ScanRanker scores than unidentified spectra. 
The second experiment evaluated the peptides gained through semi-tryptic search. 
For samples dominated by a few major proteins, this strategy improves peptide and 
protein identification. In this study, I searched the “Serum Orbi” (Ma et al. 2009) dataset 
using MyriMatch in either fully tryptic or semi-tryptic search mode. Among 6697 
MS/MS scans in the dataset, 646 spectra were identified in tryptic search, and an 
additional 928 spectra were generated by semi-tryptic search. Figure 18B plots the 
distribution of all spectra, split to deciles by ScanRanker scores. It can be observed that 
the majority of gained spectra by semi-tryptic search were ranked within the top 30% of 
spectra by ScanRanker. 
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Figure 18. Evaluation of ScanRanker to recover unidentified high quality spectra. Three 
datasets were reanalyzed by additional search methods to find high quality spectra that 
were unidentified in initial database searches. Each test represents a typical reason that 
high quality spectra may be left unidentified in an initial search. (A) The “DLD1 LTQ” 
dataset was initially identified by Sequest search. New identifications (IDs) were added 
by MyriMatch and X!Tandem searches. (B) The “Serum Orbi” data was searched by 
MyriMatch in either tryptic or semi-tryptic mode. (C) The “Histone Orbi” data was 
searched by MyriMatch. A subsequent TagRecon search was performed to identify 
spectra of mutated or modified peptides. These graphs plot the distributions of initial 
identifications, new identifications by additional searches and unidentified spectra in 
deciles by ScanRanker scores. In each panel, the left side represents spectra assigned high 
ScanRanker quality scores and the right side is low quality spectra. Newly identified 
spectra tend to associate with better ScanRanker scores in all datasets.  
 
In the third test, I examined the ability of ScanRanker to find spectra that were 
unidentified due to modifications and mutations. The “Histone Orbi” (Loecken et al. 
2009) data with 9170 MS/MS scans was initially searched using MyriMatch, yielding 
641 confidently identified spectra. To find spectra of modified peptides, the dataset was 
searched using TagRecon against a customized database consisting of identified proteins 
and decoy sequences. TagRecon yielded 672 spectra including common modifications 
such as acetylation (117 spectra) and deamidation (159 spectra). Among them, 234 
spectra were missed in MyriMatch search. Figure 18C shows the distribution of spectra 
ordered by ScanRanker scores. As in preceding plots, spectra assigned high ScanRanker 
scores were more likely to be identified through PTM identification software. 
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III.4.4 Comparison of ScanRanker to QualScore 
QualScore is a tool integrated in the Trans-Proteomic Pipeline that is specifically 
designed for recognizing spectra that evade identification. I compared the performance of 
QualScore and ScanRanker on three datasets. To obtain quality scores from QualScore, I 
analyzed the datasets using Sequest and PeptideProphet, and then processed results using 
QualScore under the default configuration. Figure 19 shows the ROC curves of 
ScanRanker and QualScore in three datasets. ScanRanker performed as reliably as 
QualScore in all tests. ScanRanker displayed slightly better performance than QualScore 
in the “Histone Orbi” data, possibly because the existence of modified peptides decreased 
the effectiveness of Sequest/PeptideProphet training, thus diminishing QualScore 
accuracy. Despite this minor difference, both tools are able to recognize unassigned high 
quality spectra. QualScore produces accurate results by training its scoring system for 
each dataset based on Sequest/PeptideProphet results, while ScanRanker evaluates 
spectral quality directly using a sequence tagging approach. Thus, ScanRanker has no 
dependence on the availability of database search results. 
I attempted to include other algorithms in this comparison. Initial tests of 
msmsEval gave promising discrimination for LTQ datasets, but no training model was 
provided to enable its use in other types of instruments. The version of the PARC filter 
(Bern et al. 2004) that I received from the Yates Laboratory omitted scores for removed 
spectra, limiting its scope to filtering spectra prior to database search.  In some other tools, 
the software simply split datasets to “good” and “bad” directories without a report of 
metrics for each spectrum, limiting conclusions about their scoring discrimination.  As a 
result of these setbacks, I limited the comparison to QualScore. 
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Figure 19. Comparison of ScanRanker to QualScore. Spectra in three datasets were 
separately processed by ScanRanker and QualScore to generate quality scores. 
ScanRanker performs as well as QualScore in all datasets but does not require 
Sequest/PeptideProphet analysis for spectral quality assessment. 
 
III.4.5 Prediction of Richness of Identifiable Spectra 
High quality spectra are more likely to be identified in proteomics data analysis. If 
multiple LC-MS/MS runs are included in an experiment, (for example, MudPIT or 1D 
gel experiments,) the number of high quality spectra in each dataset reveals the richness 
of identifiable spectra, providing a preliminary overview for the quality of the LC-
MS/MS experiment. I sought to demonstrate that the ScanRanker scores are predictive of 
relative qualities of LC-MS/MS runs in an experiment. Three published datasets, the 
“MudPIT Orbi” (Slebos et al. 2008), “IEF Orbi” (Slebos et al. 2008) and “GelBand LTQ” 
(Burgess et al. 2008) data, were searched using MyriMatch against an IPI Human 
database. ScanRanker grouped all LC-MS/MS runs in each dataset as a single experiment, 
in which the means and interquartile ranges of subscores across all fractions or gel bands 
were used for normalization to compute the quality scores.  
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Figure 20 shows the scatter plot between the number of identified spectra in each 
LC-MS/MS run and the number of retained spectra with ScanRanker scores above 
different thresholds. Here I used three score thresholds (0, 0.5 and 1). Spectra with score 
0 represent scans of better than 60-70% spectra, and spectra scoring 0.5 and 1 have better 
quality than approximately 85% and 95% of spectra in each experiment, respectively. 
The distributions of quality scores, however, are dataset-dependent. As expected, the 
number of high quality spectra predicted by ScanRanker in each dataset is highly 
correlated to the number of identified spectra. For example, a score threshold at 0.5 
produced the Pearson correlation coefficients of 0.90, 0.90 and 0.95 for “MudPIT Orbi”, 
“IEF Orbi” and “GelBand LTQ” datasets, respectively. Therefore, the relative quality of 
each LC-MS/MS run in an experiment can be estimated by the number of high quality 
spectra determined by ScanRanker. This is potentially useful for large-scale proteomic 
studies, in which ScanRanker can be used as a rapid quality control tool to highlight bad 
LC-MS/MS runs among an experiment. 
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Figure 20. ScanRanker scores predict the richness of identifiable spectra. Each point in 
the figure represents a single LC-MS/MS run and the dotted lines show the least squares 
fit of the data.  Three ScanRanker thresholds were used to count retained spectra.  9 of 10 
LC-MS/MS runs in the MudPIT dataset are plotted because the first fraction of the 
MudPIT experiment generated only 21 spectrum identifications.  Each LC-MS/MS run in 
all three datasets includes about 10000 MS/MS spectra, while the number of identified 
spectra varies dramatically. The number of spectra assigned high ScanRanker scores 
correlate to the number of identified spectra, providing relative quality assessment of LC-
MS/MS runs in an experiment. 
 
III.4.6 Use of Quality Score in Peptide Validation 
In proteomics data analysis, database search engines usually generate one or more 
scores to measure the matches between candidate peptides and experimental spectra. The 
search results are then processed by either statistical methods (e.g., PeptideProphet) or 
FDR-based methods (e.g., IDPicker) for peptide validation. In latter methods, usually 
only scores from database search tools are used to compute FDR. Here I sought to 
combine spectral quality scores and scores produced by database search tools to increase 
confident peptide identifications. I searched the “DLD1 LTQ” data using Mascot, 
Sequest and X!Tandem against an IPI Human database (v3.56). All search results were 
converted to pepXML files using either an in-house Perl script or software tools in the 
Trans Proteomics Pipeline. The spectral quality scores generated by ScanRanker were 
added to pepXML files using a Perl script. IDPicker subsequently read these scores along 
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with search engine scores during peptide validation. The software combined multiple 
scores by optimizing score weights through a Monte Carlo method, generating a single 
score for each peptide-spectrum match. In this test, I configured IDPicker to use either 
the primary scores from a database search tool or these scores plus the spectral quality 
score.  
 
 
 
Figure 21. Adding ScanRanker scores in peptide validation increases the number of 
confident spectrum identifications. “DLD1 LTQ” dataset was separately searched by 
Mascot, Sequest and X!Tandem. ScanRanker scores were added to pepXML files to 
allow score combination in IDPicker.  Mascot scores were combined using either static 
weights as “IonScore-IdentityScore” or optimized weights as “IonScore + ScanRanker”. 
Sequest and X!Tandem results were combined by enabling score weights optimization in 
IDPicker. The Venn diagrams show the percent overlap of identified spectra when using 
either a single score or combination of two scores. The latter method yielded more 
spectrum identifications for all searches.  
 
Figure 21 shows the percent overlap of confident spectrum identifications in both 
settings. Adding spectral quality scores in peptide validation consistently yielded more 
confident spectrum identifications than using a single score. Mascot benefited 
significantly more from score combination than Sequest and X!Tandem. Some spectra 
may be identified only when using the primary score. These spectra, however, are usually 
less confident identifications that are assigned marginal match scores in database search. 
 
Mascot Sequest X!Tandem 
85.7% 10.1% 4.1% 
IonScore 
-IdentityScore
  
IonScore 
+ScanRanker 
95.1% 3.1% 1.6% 
XCorr 
+deltaCN 
XCorr + deltaCN 
+ScanRanker 
 
94.4% 4.4% 1.2% 
Hyperscore Hyperscore 
+ScanRanker 
 
85 
 
 
III.4.7 Selection of Spectra for De Novo Sequencing 
De novo sequencing is an alternative, database-independent approach for peptide 
identification. However, inferring peptides from spectra is a time-consuming process. In 
this study, for example, PepNovo took about 8 hours to infer sequences of an Orbitrap 
dataset with 14217 MS/MS scans on a Dell Optiplex 745 computer with an Intel Core 2 
Duo 6400 processor and 3 GB of RAM, while ScanRanker only required 3 minutes for 
spectral quality assessment. Therefore, de novo sequencing could benefit from the 
application of spectral quality assessment tools by selecting high quality spectra for de 
novo analysis.  
As a state-of-the-art de novo sequencing tool, PepNovo assigns a score to each 
inferred peptide sequence to evaluate how well it explains the peak pattern in a spectrum. 
The higher a PepNovo score, the better an inferred peptide matches a spectrum. I 
employed three datasets to demonstrate that high ScanRanker scores are predictive of 
high PepNovo scores. The initial comparison of these scores analyzed the “Yeast Velos” 
dataset, in which peptide identification was straightforward. Figure 22A shows the scatter 
plot between the PepNovo score of the top ranked peptide sequence for each spectrum 
and its ScanRanker score. ScanRanker scores are highly correlated to PepNovo scores, 
producing a Pearson correlation coefficient of 0.82. As expected, spectra identified by 
MyriMatch search tend to associate with high ScanRanker and PepNovo scores. 
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Figure 22. ScanRanker scores can be used to predict de novo sequencing success. Spectra 
in three datasets were separately processed by ScanRanker and PepNovo.  Identifications 
were generated by searching the spectra using MyriMatch. For clarity, only 1000 spectra 
were randomly sampled and displayed. When PepNovo reported no peptide for a 
spectrum, it was visualized as matching the minimum score reported by the software for 
that dataset. Panel C highlights five published key spectra from the Asara group 
publication. In all three tests, spectra with high ScanRanker scores tend to be assigned 
high PepNovo scores, implying that ScanRanker can be used to select high quality 
spectra for de novo sequencing. 
 
Next, I evaluated ScanRanker on datasets for which de novo sequencing would be 
necessary. The “Tardigrade QSTAR” dataset is an LC-MS/MS experiment from a 1D gel 
band from a species of microscopic animals for which genome sequence is unavailable. 
MyriMatch attempted to produce identifications in a customized database containing 
proteins of three species that are taxonomically similar to tardigrade (Drosophila 
melanogaster (DROME), Anopheles gambiae (African malaria mosquito, ANOGA) and 
Caenorhabditis elegans (CAEEL)). Only spectra for peptides of highly similar proteins 
would be identified by this approach; only 66 spectra were identified among the 837 
MS/MS scans in the set. Figure 22B superimposes these identifications on the scatter plot 
of PepNovo and ScanRanker scores. PepNovo and ScanRanker both report that many 
spectra were of high quality and yet failed identification. Pearson correlation between the 
two algorithms produced a coefficient of 0.72.  
(A) (B) (C) 
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Considerable controversy has accompanied the recent publication of proteomics 
data for fossilized specimens (Schweitzer et al. 2009). I sought to characterize the recent 
“Hadrosaur Orbi” dataset to evaluate the inherent identifiability of spectra for these 
spectra. I began with a database search against a lizard (Anolis carolinensis) database, 
AnoCar1.0, produced by the Broad Institute (http://www.broadinstitute.org/models/anole). 
The result included 189 confidently identified tandem mass spectra, but all matched to 
keratin or trypsin sequences (our database did not include the chicken sequences 
employed by the Asara group). I plotted spectra against the corresponding PepNovo and 
ScanRanker scores (see Figure 22C). Five collagen spectra from the original Asara 
publication were assigned high ScanRanker quality scores of 1.13, 0.99, 0.97, 1.01 and 
1.70; I was unable to match the sixth identification to the corresponding MS/MS 
spectrum. The hadrosaur data produced the lowest correlation between PepNovo and 
ScanRanker (0.34), where the best correspondence could be observed in the high scoring 
domains for the two algorithms. It becomes clear that the data of the “Hadrosaur Orbi” 
set were disproportionately likely to produce PepNovo scores below zero, suggesting that 
a large fraction of spectra from this dataset could not support confident sequence 
identifications even if appropriate sequences were available in FASTA. 
 
III.4.8 Use of ScanRanker in Cross-linking Analysis 
Identification of cross-linked peptides by mass spectrometry is a challenging task, 
mainly because of the high complexity and often low signal intensity in these spectra. 
Even with the availability of advanced computational tools, manual interpretation or 
confirmation of cross-linked peptides is generally necessary. Here I sought to 
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demonstrate that ScanRanker helps to prioritize spectra for manual inspection. The 
published “Crosslink Orbi” (Trnka & Burlingame 2010) dataset consists of 1161 MS/MS 
spectra collected on an LTQ-Orbitrap XL with an ETD module installed (Thermo 
Scientific). Spectra in quadruply charged or higher charge states were selected for ETD 
fragmentation to characterize chemically cross-linked GroEL-GroES chaperonin complex. 
Protein Prospector (Chu et al. 2010) identified 55 spectra of cross-linked peptides 
(manually confirmed) and 91 spectra of single peptides. Figure 23 shows the distribution 
of these spectra, split to deciles by ScanRanker scores. The spectra of cross-linked 
peptides were associated with high ScanRanker scores, suggesting that ScanRanker is 
capable of recognizing these spectra, though they are more complicated than spectra of 
single peptides. The results also indicate that ScanRanker performs well for spectra from 
ETD fragmentation.  
Some spectra were assigned high quality scores but remained unidentified. A 
manual inspection of these spectra implies that they are likely produced by peptides 
rather than non-peptide contaminants. These spectra usually contain a large number of 
peaks. For example, the top 10% of spectra by ScanRanker includes 70 unidentified 
spectra. The average number of peaks in these spectra is 228, which is much higher than 
that number of all spectra (91 peaks) in the dataset. 
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Figure 23. ScanRanker helps to prioritize spectra for manual inspection in cross-linking 
analysis. The “Crosslink Orbi” dataset was processed using Protein Prospector to identify 
crosslinked and non-crosslinked spectra. The figure plots the distribution of these spectra 
in deciles by ScanRanker scores. The identified spectra, either crosslinked or non-
crosslinked, were associated with high ScanRanker scores, implying that ScanRanker can 
be used to facilitate cross-linking analysis by ranking spectra for manual inspection. 
 
 
III.5 Conclusion 
I present a method that assesses quality of tandem mass spectra through sequence 
tagging. ScanRanker does not require training for each type of data from different mass 
spectrometers, broadening its use to lab researchers lacking prior experience in statistical 
learning. In this study, I employed a variety of datasets to demonstrate the effectiveness 
of ScanRanker for recovery of unidentified high quality spectra and removal of low 
quality spectra. I showed that ScanRanker can be used to predict the richness of 
identifiable spectra in LC-MS/MS experiments and to improve peptide validation. I also 
demonstrate the application of our method to rank spectra for de novo sequencing and 
Low High 
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cross-linking analysis. The superior performance of ScanRanker established it as a robust 
and reliable spectral quality assessment tool. 
Wrapping ScanRanker to a library function will improve its usability, making it 
easy to be integrated into other software tools. For example, it can be used as a pre-
processor for database search engines to filter out low quality spectra; it can be integrated 
to IDPicker to provide quality scores for spectral identifications and export unidentified 
spectra for subsequent analysis; it can be incorporated into QuaMeter (described in next 
chapter) to replace the identification step and conduct instrument QC based on the 
identifiable spectra rather than identified spectra. 
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CHAPTER IV 
 
QUAMETER: MULTI-VENDOR PERFORMANCE METRICS FOR LC-MS/MS 
PROTEOMICS INSTRUMENTATION  
 
IV.1 Introduction 
Technologies for proteomic identification via LC-MS/MS rely on a complex 
series of experiments: protein denaturation and digestion, LC separation of peptides 
followed by electrospray ionization, tandem mass spectrometry, and proteome 
informatics. Variation in the performance for any of these elements may impact 
proteomic identification.  The publication of LC-MS/MS quality metrics by Paul Rudnick 
at NIST, working in collaboration with the National Cancer Institute (NCI) CPTAC 
network, introduced a set of metrics that span this complex process (Rudnick et al. 2010), 
enabling recognition of components that were operating at variance with their typical 
performance.  The strategy makes use of defined quality control samples that are 
periodically analyzed between experimental samples in a queue for the mass 
spectrometer. 
The previously described 46 metrics embodied in the NIST MSQC software rely 
on a complex set of algorithms. Data from Thermo RAW files are first transcoded to 
mzXML, MS1, and MGF formats for subsequent processing. The MS1 files enable 
peptide precursor ion chromatograms to be assessed in the NIST ProMS software. The 
tandem mass spectra of an LC-MS/MS experiment are identified by either the SpectraST  
spectral library search engine or the OMSSA data-base search algorithm. The MSQC 
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software can then match precursor ion chromatograms with peptide identifications to 
compute its set of metrics and report them to a text file. 
In practice, several aspects of the MSQC software prevent its use for routine 
instrument monitoring. Its reliance on a modified ReAdW tool for reading raw data limits 
its application to instruments from Thermo Fisher. The coordination among different 
software packages may lead to mis-association of peptide identifications and tandem 
mass spectra when alternative file formats or high scan rate instrumentation are employed.  
Adapting the pipeline for site-specific workflows (such as a different peptide 
identification engine) is a non-trivial task. 
In this work, I present the QuaMeter tool that has the same capabilities as MSQC 
with several important additions. QuaMeter can read files from most mass spectrometry 
vendors via ProteoWizard and does not lose time trancoding to other formats. The 
software accepts identification data from IDPicker, so any identification database search 
engine that produces pepXML or mzIdentML can be used. I demonstrate the use of 
QuaMeter for data collected from instrument of three different vendors. I examine the 
impact of identifications tools on computed metrics. The improvements in QuaMeter 
make it a robust and flexible quality metric assessor with open source.  
 
IV.2 Overview 
To compute QC metrics for a LC-MS/MS experiment, QuaMeter requires two 
input files: an instrument spectral file and an identification search engine results file. As 
shown in Figure 24, ProteoWizard is central to data management for the software 
pipeline.  Its support for native file formats from multiple instrument vendors means that 
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transcoding data to an open format is unnecessary (although support for non-Microsoft 
Windows systems would require this step).  ProteoWizard presents spectra in an mzML 
data model to all of the pictured tools, using uniform “nativeID” labels to relate 
identifications to source scans.  Its incorporation of a chromatogram extractor from 
Crawdad (Finney et al. 2008) supports the full-width-at-half-maximum computations 
needed for the quality metrics.   
 
  
 
Figure 24. Workflow diagram for QuaMeter operation. 
 
The peptide identification tools such as MyriMatch (database search), TagRecon 
(sequence tag-based database search), and Pepitome (spectral library search) all 
incorporate ProteoWizard for both data import and identification export via pepXML and 
mzIdentML formats.  Here I emphasize Pepitome since spectral library search is 
particularly appropriate for repeat identification of QC standard samples.  Raw 
identifications from this step are filtered within the IDPicker protein assembler, and 
filtered identifications are processed by QuaMeter to compute QC metrics. For each LC-
MS/MS run, QuaMeter exports metrics to a table in text format.  
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IV.3 Data Sources 
I tested QuaMeter on several datasets spanning six instruments from three 
different vendors (see Table 4). These datasets were accumulated via QC experiments in 
three laboratories to monitor instrumentation performance.. 
 
Dataset  Sample 
# of 
files 
Average # of 
MS/MS scans Databases used for search 
LTQ-XL BSA 280 11917 RefSeq.BOVINE  
LTQ-Orbitrap BSA 53 3417 RefSeq.BOVINE 
LTQ-Velos Yeast 5 38466 SGD.orf_trans_all 
HCT Ultra BSA 24 3467 RefSeq.BOVINE 
QSTAR Elite Beta-gal 23 451 UniProt.ECOLI 
TripleTOF 5600 Beta-gal 60 1973 UniProt.ECOLI 
 
Table 4. Experimental datasets for the evaluation of QuaMeter.  
 
All datasets were searched using MyriMatch or Pepitome, and search results were 
processed by IDPicker software for peptide validation and protein assembly. Throughout 
this study, IDPicker was configured to derive score thresholds to yield a 5% FDR. 
Filtered identifications and spectral files were processed by QuaMeter to compute QC 
metrics. To compare metrics generated by QuaMeter and MSQC, scripts in Awk were 
created to make IDPicker identifications accessible to MSQC so that both algorithms 
could work from a common set of identifications. Data processing details and software 
parameters are available in Appendix A. 
 
Thermo Fisher LTQ-XL Dataset 
This data constitutes of 280 routine BSA runs at the Jim Ayers Institute for 
Precancer Detection and Diagnosis at Vanderbilt University. The dataset was previously 
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used to test the Pepitome software and the experimental description is published by 
Dasari et al. (Dasari et al. 2012). The files average 11917 MS/MS scans each. All files 
were searched using MyriMatch against a RefSeq BOVINE database or using Pepitome o 
match the NIST BSA spectral library (http://peptide.nist.gov). 
 
Thermo Fisher LTQ-Orbitrap Dataset 
This dataset was also collected at the Jim Ayers Institute for Precancer Detection 
and Diagnosis at Vanderbilt University. Experimental settings were exactly the same as 
above except 10x BSA peptide mixtures were used instead of 1x BSA. All samples were 
analyzed on a Thermo Fisher LTQ-Orbitrap mass spectrometer. A total of 53 files were 
used in this manuscript. Spectra were searched using MyriMatch against a RefSeq 
BOVINE database. The files average 3417 MS/MS scans. 
 
Thermo Fisher LTQ-Velos Dataset 
This is the same dataset as described above for testing the ScanRanker software. 
Five technical replicates were collected for a yeast lysate on a Thermo Fisher LTQ-Velos 
instrument. The files average 38466 MS/MS scans each. Spectra were identified using 
MyriMatch against a yeast database (http://www.yeastgenome.org) downloaded on 
March 2009. All files were also searched by Pepitome against the NIST yeast spectral 
library (http://peptide.nist.gov).   
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Bruker Daltonics HCT Ultra Dataset 
Stock BSA solution prepared in 100mM ammonium bicarbonate buffer was 
digested overnight with sequencing grade Trypsin (Promega) at enzyme-to-substrate ratio 
of 1:50 at 37°C. LC-MS/MS analysis was carried out on an Eksigent 1D-nanopump 
coupling to a Bruker HCT Ultra iontrap mass spectrometer. The mobile phases were 
water and acetonitrile with 0.1% formic acid as an additive. 2uL of working BSA 
solution of 100fmol/uL was load by a FAMOS autosampler with a 10uL sample loop 
onto a 3cm, 360/100 OD/ID trap column of 5um Jupiter C18 particles with loading 
aqueous buffer of 0.1% formic acid at flow rate of 1uL/min and separated on a 15cm 
360/75um OD/ID PicoFrit emitter column from New Objective packed with 3um Jupiter 
C18 particles. Both columns were in house packed. Tryptic peptides eluted during a 
gradient from 2% to 50% acetonitrile at flow rate of 250nL/min. Different LC-gradients 
were applied throughout the data collection. LC-MS/MS data was acquired in positive 
ionization mode with scan segments of 1 precursor ion scan (m/z=375-2000) in standard 
enhanced and 3 subsequent tandem MS scans of three most abundant ions in ultra scan 
mode. Scan average was set to 2 and ion charge control (ICC) was 200,000. Singly 
charge ions were excluded from tandem MS and a 1 minute dynamic exclusion was 
activated for each peptide after two MS tandem acquisitions.  
Instrument raw files were converted to mzML format by the MSConvert tool in 
ProteoWizard. Since Bruker data extraction library does not write precursor spectrum 
reference information in mzML files, which is required for running QuaMeter, a Perl 
script is created to add precursor spectrum references to MS/MS scans. The latest 
previous MS1 scan is assumed as the precursor of neighboring MS/MS scans. 24 files 
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were collected with averagely 3467 MS/MS scan each.  All spectra were searched using 
MyriMatch against a RefSeq BOVINE protein database and identifications were filtered 
by IDPicker.  
 
AB SCIEX QSTAR Elite Dataset 
Predigested, tryptic beta-galactosidase solutions (E. coli) were obtained from AB 
SCIEX and used as quality control samples. Samples were analyzed by reverse-phase 
nano-HPLC-ESI-MS/MS using an Eksigent nano-LC 2D HPLC system (Eksigent, Dublin, 
CA) which was directly connected to a quadrupole time-of-flight (QqTOF) QSTAR Elite 
mass spectrometer (AB SCIEX, Concord, CAN).  Briefly, peptide mixtures were loaded 
from the autosampler (using partial loop fill methods) onto a guard column (C18 Acclaim 
PepMap100, 300 µm I.D. x 5 mm, 5 µm particle size, 100 Å pore size, Dionex, 
Sunnyvale, CA) and washed with the loading solvent (0.1 % formic acid, flow rate: 20 
µL/min) for 5 min. Subsequently, samples were transferred onto the analytical C18-
nanocapillary HPLC column (C18 Acclaim PepMap100, 75 µm I.D. x 15 cm, 3 µm 
particle size, 100 Å pore size, Dionex, Sunnyvale, CA) and eluted at a flow rate of 300 
nL/min using the following gradient:  2-30% solvent B in A (from 0-15 min), 30-80% 
solvent B in A (from 15-17 min) and at 80% solvent B in A (from 17-20 min), with a 
total runtime of 52 min (including mobile phase equilibration). Solvents were prepared as 
described below for the TripleTOF 5600. Mass spectra (ESI-MS) and tandem mass 
spectra (ESI-MS/MS) were recorded in positive-ion mode with a resolution of 12,000-
15,000 full-width half-maximum. For collision induced dissociation tandem mass 
spectrometry (CID-MS/MS), the mass window for precursor ion selection of the 
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quadrupole mass analyzer was set to ± 1 m/z.  The precursor ions were fragmented in a 
collision cell using nitrogen as the collision gas. Advanced information dependent 
acquisition (IDA) was used for MS/MS collection, including QSTAR Elite (Analyst QS 
2.0) specific features, such as “Smart Collision” and “Smart Exit” (fragment intensity 
multiplier set to 2.0 and maximum accumulation time at 2.5 sec) to obtain MS/MS 
spectra for up to seven most abundant precursor ions following each survey scan.  
Dynamic exclusion features were based on value M not m/z and were set to exclusion 
mass width 50 mDa and exclusion duration of 60 sec. All 23 files were searched using 
MyriMatch against a UniProt E.coli database and identifications passing 5% FDR in 
IDPicker analysis were confident IDs. 
 
AB SCIEX TripleTOF 5600 Dataset 
Predigested, tryptic beta-galactosidase solutions (E. coli) were obtained from AB 
SCIEX and used as quality control samples. Samples were analyzed by reverse-phase 
HPLC-ESI-MS/MS using an Eksigent Ultra Plus nano-LC 2D HPLC system (Dublin, CA) 
which was directly connected to a new generation quadrupole time-of-flight (QqTOF) 
TripleTOF 5600 mass spectrometer (AB SCIEX, Concord, CAN) in direct injection 
mode.  The autosampler was operated in full injection mode overfilling a 1 µl loop with 3 
µl analyte for optimal sample delivery reproducibility. Briefly, after injection, peptide 
mixtures were transferred onto the analytical C18-nanocapillary HPLC column (C18 
Acclaim PepMap100, 75 µm I.D. x 15 cm, 3 µm particle size, 100 Å pore size, Dionex, 
Sunnyvale, CA) and eluted at a flow rate of 300 nL/min using the following gradient: at 
5% solvent B in A (from 0-13 min), 5-35% solvent B in A (from 13-29 min), 35-80% 
99 
 
solvent B in A (from 29-31 min) and at 80% solvent B in A (from 31-37 min), with a 
total runtime of 58 min including mobile phase equilibration.  Solvents were prepared as 
follows, mobile phase A: 2% acetonitrile/98% of 0.1% formic acid (v/v) in water, and 
mobile phase B: 98% acetonitrile/2% of 0.1% formic acid (v/v) in water.  Mass spectra 
and tandem mass spectra were recorded in positive-ion and “high-sensitivity” mode, with 
a resolution of ~35,000 full-width half-maximum in MS1 mode and ~15,000 in MS/MS 
mode.  The nanospray needle voltage was 2,400 V in HPLC-MS mode.  After acquisition 
of ~ 5 to 6 samples, TOF MS spectra and TOF MS/MS spectra were automatically 
calibrated during dynamic LC-MS & MS/MS autocalibration acquisitions injecting 25 
fmol beta-galactosidase. For collision induced dissociation tandem mass spectrometry 
(CID-MS/MS), the mass window for precursor ion selection of the quadrupole mass 
analyzer was set to ± 1 m/z. The precursor ions were fragmented in a collision cell using 
nitrogen as the collision gas. Advanced information dependent acquisition (IDA) was 
used for MS/MS collection on the TripleTOF 5600 (Analyst TF 1.5) to obtain MS/MS 
spectra for the 20 most abundant precursor ions following each survey MS1 scan 
(allowing for 50 msec acquisition time per each MS/MS). Dynamic exclusion features 
were based on value M not m/z and were set to an exclusion mass width of 50 mDa and 
an exclusion duration of 15 sec. All 60 files were searched using MyriMatch against a 
UniProt E.coli database and processed by IDPicker.  
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IV.4 Results and Discussion 
IV.4.1 Differences between QuaMeter and MSQC 
Validating QuaMeter performance began with a comparison of the values 
computed by MSQC and QuaMeter. I modified MSQC to accept the same identified 
peptides from IDPicker as did QuaMeter. BSA QC runs collected on a Thermo Fisher 
LTQ-XL mass spectrometer were identified by Pepitome using the NIST ion trap spectral 
library (http://peptide.nist.gov), and IDPicker filtered the results to a 5% FDR. Scripts 
converted the filtered identifications for MSQC handling. 
Figure 25 illustrates the correspondence between QuaMeter and MSQC outputs 
for a set of representative metrics. Median precursor m/z error for +2 peptides (MS1-5A 
in NIST nomenclature) is shown in the top-left panel as a representative of metrics with 
very good agreement between both implementations. Most metrics representing peptide 
identifications (such as P-2A, P-2B, P-2C and P-3) yielded similar results. 
The key C-2A metric was a note of discord between QuaMeter and MSQC. This 
metric, describing the duration of time in which the middle 50% of peptides are identified, 
disagreed even when QuaMeter attempted to emulate MSQC behavior closely (top-right 
panel in Figure 25). Inspection of the code revealed that MSQC vacillates in whether or 
not modifications or precursor charge differentiate identifications. Because C-2A plays a 
role in the computation of many other metrics, the QuaMeter implementation was 
changed to a “distinct modified peptide” rule (under which either a sequence difference 
or a modification change resulted in the identification counting as a new peptide). Since 
distinct modified forms for a peptide sequence may chromatographically elute differently, 
this change leads to a more representative metric. 
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Figure 25. QuaMeter generates similar metrics as MSQC except several chromatographic 
metrics due to the use of distinct chromatogram extraction tools. Metrics were generated 
from BSA QC experiments collected on a Thermo Fisher LTQ-XL mass spectrometer. 
 
Because MSQC and QuaMeter extract chromatographic data by distinct tools, 
differences in peak intensity and width are unsurprising. Metric DS-3B evaluates the 
maximum intensity versus the intensity at the time when MS/MS was triggered for the 
50% of peptides with the least intense trigger intensities (see bottom-left panel in Figure 
25). The MSQC software estimated far lower peak intensity maxima than expected from 
manual inspection, resulting in little correlation for this metric. This effect propagated 
through metrics describing the chromatographic process as well as dynamic sampling.  
Metric C-3A (lower-right panel in Figure 25) reports the median peak width (FWHM) for 
identified peptides. QuaMeter, via Crawdad, generally reports lower peak widths than 
QuaMeter 
M
SQ
C
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does the MSQC code. It should be noted that this comparison was performed using an 
early version of MSQC that uses a modified ReAdW tool for chromatogram extraction. 
This strategy has been deprecated in updated MSQC in favor of the ProMS tool that may 
produce more reliable chromatographic data (P. Rudnick, personal communications). I 
was unable to acquire a recent build of ProMS for comparative testing. 
 
* * * *
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abundance 
peptide
Low 
abundance 
peptide
AB SCIEX
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Bruker Daltonics
HCT Ultra
Thermo Fisher
LTQ-XL
 
 
Figure 26. QuaMeter generates reliable chromatographic data in instruments from 
multiple vendors via the Crawdad function in ProteoWizard. Red lines represent 
experimentally measured intensities in MS and blue lines are extracted ion 
chromatograms generated by Crawdad. Asterisks for the low abundance peptides signify 
the acquisition times for identified MS/MS scans. 
 
Because the Crawdad function has been implemented in the ProteoWizard library, 
QuaMeter can extract chromatographic data from all major vendor formats. QuaMeter 
provides an option to export chromatographic data in mz5 format (Wilhelm et al. 2012) 
which can be visualized by the SeeMS tool in ProteoWizard. Figure 26 illustrates the 
extracted ion chromatograms (XIC) of experimentally measured intensities and modeled 
peaks generated by Crawdad. XIC of representative peptides from three instrument 
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platforms were displayed. For high abundance peptides that were identified with many 
MS/MS scans, Crawdad produced well-fitted chromatograms that match experimental 
data (top panels in Figure 26). In addition, Crawdad also showed excellent performance 
for low abundance peptides with noisy experimental XIC or interfering peaks (bottom 
panels in Figure 26). QuaMeter chromatogram extraction is improved by using the 
precursor mass calculated from identified peptides and by noting the retention times of 
identified MS/MS scans. 
 
IV.4.2 Multi-vendor Performance 
To test QuaMeter’s compatibility with instruments from multiple vendors, I 
employed several datasets collected from Thermo Fisher LTQ-XL, LTQ-Orbitrap, LTQ-
Velos, Bruker Daltonics HCT Ultra, AB SCIEX QSTAR Elite and AB SCIEX TripleTOF 
5600 mass spectrometers. Instrument raw files from Thermo and Bruker were converted 
to mzML format using the MSConvert tool in ProteoWizard. AB SCIEX data were 
converted to mzML files using the AB SCIEX MS Converter (version 1.2). All data were 
searched by MyriMatch and search results were processed by IDPicker. Filtered 
identifications were then processed by QuaMeter to compute QC metrics.  
Rather than evaluate instrumentation performance solely based on the number of 
identifications, QuaMeter provides six categories of QC metrics that monitor 
chromatographic performance, electrospray source stability, MS1 and MS2 signals, 
dynamic sampling of ions and peptide identification. For example, Figure 27 illustrates a 
set of selected metrics describing the chromatographic process for five instruments.  
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Figure 27. QuaMeter computes QC metrics for multiple instrument platforms. Standard 
samples such as BSA or beta-galactosidase were analyzed for routine instrument 
evaluation. C-2A: time period over which middle 50% of peptides were identified. C-4A, 
C-4B, C-4C: median peak width for identified peptides in first, last and median RT decile. 
 
These plots reflect experimental settings and reveal instrument performance 
variability. First, the C-2A metric, the duration of time in which the middle 50% of 
peptides are identified, is very small for the AB SCIEX TripleTOF 5600 and QSTAR 
Elite dataset, implying that peptides were eluted in a short time period. This is because a 
very short LC gradient was applied for peptide separation in these experiments. Second, 
the variation of C-2A metric is relatively large for the Bruker Daltonics HCT Ultra data. 
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This is because different BSA samples for this instrument were separated by different 
HPLC columns and gradients. Likewise, large variations were also observed for other QC 
metrics computed for this dataset such as the number of identifications (data not shown). 
Third, peak widths of identified peptides were not evenly distributed across retention 
time in all tests. The C-4A, C-4B and C-4C metrics report median peak width for 
identified peptides in the early, late and middle retention time, respectively. It can be 
observed that peak width for all instruments varies with retention time. These plots 
demonstrate the cross-instrument capabilities of ProteoWizard and QuaMeter.  
QuaMeter metrics can be used to spot abnormal instrument performance. For 
example, early analysis of TripleTOF 5600 data recognized six files as outliers compared 
to other QC experiments.  As shown in Figure 28, very low numbers of identifications 
were generated from these six files (top-left panel), and a close examination of QuaMeter 
metrics showed that they associated with high precursor mass accuracy errors (bottom-
left panel). The instrument log revealed that these files had a mass accuracy shift due to 
temperature variation (caused by air handler failure within the laboratory). Recalibrating 
these files yielded narrow precursor errors and comparable number of identifications as 
other experiments (right panels in Figure 28). 
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Figure 28. QuaMeter metrics help to spot abnormal instrument performance. Metrics 
computed from TripleTOF data were plotted by date. Six files were recognized as outliers 
in early analysis that had very low number of identifications (blue box in top-left P-2A 
metric) and high precursor mass accuracy errors (blue box in bottom-left MS1-5A metric; 
one point missing for 111104 because zero identification passed 5% FDR threshold from 
this file). Recalibrating these files yielded narrow precursor errors (bottom-right panel) 
and comparable number of identifications as other experiments (top-right panel). 
 
IV.4.3 Impact of identification tools 
Because QuaMeter relies on identified peptides to compute QC metrics, different 
tools for identification may yield different QuaMeter metrics. To evaluate this impact in 
generating QC metrics, I employed a yeast lysate dataset with five technical replicates 
analyzed on a Thermo Fisher LTQ-Velos mass spectrometer. The files average 38466 
MS/MS scans each. This test demonstrates that QuaMeter works well not only for simple 
samples such as BSA and beta-galactosidase but also for complex mixtures. Spectra were 
identified either through database search by MyriMatch or through spectral library search 
by Pepitome. Both identification tools exported search results in pepXML format for 
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processing by IDPicker for peptide validation and protein assembly. Filtered 
identifications were then read by QuaMeter for QC evaluation. Because it accepts filtered 
identifications from IDPicker, any workflow in which identification tools produce search 
results in pepXML or mzIdentML format can also support QC. 
Figure 29 plots a set of selected QuaMeter metrics, one from each of the six 
categories, computed based on MyriMatch and Pepitome identifications. Some metrics 
shifted when the source of identifications changed. For example, the spectral library 
search by Pepitome identified around 15% more spectra than using MyriMatch (see P-2A 
in Figure 29). However, changing identification tools does not lead to substantial changes 
for most metrics. In addition, although identification tools produced different QC metrics, 
the variation for the five replicates from MyriMatch search resembled that seen from 
Pepitome. Therefore, it is very likely that the identification tool has limited effect in 
accessing analytical system performance and technical variability. Given the fact that a 
spectral library search is usually much faster than a typical database search, Pepitome, 
coupled with QuaMeter, provides a practical solution for routine identification and 
analysis of standard QC samples.  
 
108 
 
10500 12000
M
M
PP
P-2A
29.0 30.0
M
M
PP
C-2A
7300 7600
M
M
PP
DS-2B
0.22 0.28 0.34
M
M
PP
IS-3B
0.110 0.120
M
M
PP
MS1-5A
605 620 635
M
M
PP
MS2-3
  
 
Figure 29. Distinct identification tools produce different QC metrics with similar 
variation. Five technical replicates of yeast lysate samples were analyzed on a Thermo 
Fisher LTQ-Velos mass spectrometer. Spectra were identified by MyriMatch (MM) and 
Pepitome (PP) separately. Identifications from each search engine were used to compute 
QC metrics. P-2A: Number of MS2 spectra identifying tryptic peptide ions; C-2A: Time 
period over which middle 50% of peptides were identified; DS-2B: Number of MS2 
scans taken over C-2A. IS-3B: Number of 3+ peptides over 2+ peptides; MS1-5A: 
Median real value of precursor errors; MS2-3: Median number of peaks in MS2 scans. 
 
IV.5 Conclusion 
I presented an open-source tool that computes objective metrics for the evaluation 
of shotgun proteomics instrumentation performance. QuaMeter advances the previous 
MSQC tool by supporting most mass spectrometer vendors via the use of the 
ProteoWizard library. The ability to work with IDPicker identification data allows it to be 
incorporated to any identification workflow that produces pepXML or mzIdentML files. 
The improvements in QuaMeter make it a reliable and flexible tool for shotgun 
proteomics QC analysis.   
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Although QuaMeter supports native file formats from multiple instrument 
vendors, many time native files are converted to open formats in data analysis pipeline. 
QuaMeter requires the same spectral file that the database search engine was fed with. In 
additional, drawing conclusions from QuaMeter output is less well-established now. 
Another ongoing project is developing a statistical method based on QuaMeter metrics to 
enable on-the-fly instrument QC. A subset of key metrics need be determined to evaluate 
the analytical systems in routine practice.  
Future directions for QuaMeter include a number of goals.  First, recording 
metrics for experiments to a database rather than a collection of text files will greatly 
improve the production utility of the software.  Second, incorporating assessments of 
MS/MS quality by ScanRanker would be much faster and more adaptable than 
incorporating peptide identifications. Optimizing the strategies by which metric values 
can be evaluated to diagnose sources of instrument variability will be essential.  As these 
techniques mature, QC metrics promise to automate recognition of instrument 
inconsistency before critical samples are wasted.   
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CHAPTER V 
 
DISCUSSION 
 
V.1 Summary of Results 
The work in this dissertation described three new software tools for shotgun 
proteomics data analysis (see Figure 30). The QuaMeter tool focuses on instrumentation 
quality control to assure that data fed into analysis pipeline are collected under stable 
instrument performance. The IDBoost tool focuses on rescuing spectral identifications 
after initial data analysis. Spectra that are not identified after IDBoost can be further 
recovered by the ScanRanker tool for advanced searches. Each tool was developed to 
solve one aspect of problems, but together they work coordinately to provide an 
improved shotgun proteomics data analysis pipeline. 
The IDBoost tool provides a simple and efficient way to rescue spectral 
identifications from current analysis. It incorporates identification evidence of similar 
spectra and applies a rating method to determine the majority vote of these spectra. 
Spectra that were discarded in original analysis due to the failure of passing confidence 
threshold can be rescued in subsequent data analysis. Meanwhile, IDBoost corrects 
database search errors by taking into account search results from a cluster of similar 
spectra. In this dissertation, I demonstrated its applications in phosphorylation studies and 
spectral count based comparative analysis. IDBoost helps to solve phosphorylation site 
ambiguity and improves spectral count based quantification. In addition, IDBoost was 
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implemented in IDPicker, which provides a graphical user interface for interactive 
validation of rescued identifications.  
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Figure 30. A summary of three bioinformatics tools in proteomics data analysis workflow. 
 
IDBoost expands spectral identifications based on existing analysis. This is one of 
its advantages because it does not require additional identification steps. However, this 
also limits its usage because no new peptides will be added to the analysis. In practice, 
IDBoost should be used as a quick tool to rescue identifications after IDPicker analysis. 
To find more peptides, a subset of unidentified spectra can be exported by ScanRanker 
for subsequent advanced searches. 
The ScanRanker tool is a tandem mass spectral quality assessor that recognizes 
the potentially identifiable MS/MS scans. The core of ScanRanker is the DirecTag 
sequence tagging program. ScanRanker evaluates the quality of tandem mass spectra by 
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examining how well sequence tags can be inferred from each spectrum. It can be used to 
recognize unidentified high quality spectra after IDPicker and IDBoost analysis. In this 
dissertation, I demonstrated the use of ScanRanker to select spectra for de novo 
sequencing and cross-linking analysis. This tool can also be used to predict the richness 
of identifiable spectra among multiple LC-MS/MS runs in an experiment. ScanRanker is 
particularly useful for analyzing samples lacking accurate genome annotations. To 
improve its usability, I made a GUI to run ScanRanker and also a program to view the 
results. The IonMatcher viewer allows interactive validation of peptide-spectrum-
matches and offers an interface for de novo sequencing of unidentified spectra. 
The QuaMeter tool is another quality assessor but focuses on the evaluation of 
analytical systems rather than tandem mass spectra. The goal of this project is to provide 
a quality control tool that can be used in many labs for routine instrument monitoring. 
QuaMeter supports most mass spectrometry vendors via ProteoWizard and does not 
require transcoding instrument raw files to other format, making it a fast and easy-to-use 
QC assessor. Because it works with IDPicker identifications, QuaMeter is flexible to be 
integrated into any existing workflow that generates pepXML or mzIdentML. In this 
dissertation, I demonstrated the use of QuaMeter for data collected from different 
vendors. 
 
V.2 Future Direction 
V.2.1 Peptide Identification 
A critical component in proteome informatics is the scoring system that interprets 
observed spectra to peptide sequences. New technologies emerged in the past few years 
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have greatly increased the quality of proteomics data, while the informatics tools is 
slowly catching up. For example, ETD and CID are complementary fragmentation 
methods to cover both long and short peptides. Peptide ions can now be selectively 
fragmented on either ETD or CID mode (Swaney et al. 2008). However, it is challenging 
to combine the information obtained by ETD and CID in a single search. Because they 
generate totally different fragment ions, different scoring schemes need to be developed 
to process ETD and CID data separately. Even the same scoring method can be adapted 
to work for both fragmentation methods, the score distribution may differ substantially, 
making it difficult to combine the search results.  
Current scoring systems usually only consider major fragment ions such as b and 
y ions for CID fragmentation. Adding other abundant ions in scoring schemes may 
improve the discrimination power between correct and incorrect assignments. For 
example, LTQ-Orbitrap data under HCD fragmentation retains low mass and immonium 
ions, which can be considered in scoring methods to improve peptide identification. 
Understanding gas-phase fragmentation chemistry is very important for the 
development of scoring schemes. Unfortunately, current fragmentation model in most 
database search tools predict theoretical spectra far away from the experimental data. The 
massive amount of MS/MS data being confidently interpreted and deposited to public 
repositories helps the development of sophisticate fragmentation models to predict 
accurate fragment ions and their intensities.  
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V.2.2 PTM Identification and Validation 
 Identification of PTM is still a challenging issue even with the recent 
improvements in MS instrumentation and enrichment methods. For example, one 
problem to identify phosphopeptides is that a large number of phosphopeptides 
undergoes beta-elimination reaction (loss of phosphate group) rather than backbone 
fragmentation under CID. This reduces fragment ion signals in MS/MS spectra, making it 
difficult to identify these peptides. As a result, complementary techniques such as ETD or 
MS/MS/MS spectrum may be required for data acquisition. In recent years, experimental 
platforms have been greatly improved for PTM analysis, while no substantial progress 
has been made in computational tools. Advanced algorithms that take advantage of the 
state-of-art technologies are desirable for accurate and large-scale PTM analysis. 
 PTM validation is also a difficult problem. Conventional validation methods may 
not be appropriate for PTM validation because the assumptions for these methods are 
likely to be violated. For example, the target-decoy based FDR approach assumes a one-
to-one correspondence between incorrect target hits and decoy hits, while there is a much 
lower prior likelihood of observing a modified peptide compared to a non-modified 
peptide. As a result, the error rate estimated for the analysis may not be accurate. Future 
developments on advanced methods for PTM validation are necessary. 
  
V.2.3 Next Generation Sequencing and Proteomics 
Interpretation of proteomics data relies heavily on the protein databases, which 
are usually translated from genome DNA sequences. Over the past few years, there have 
been remarkable advances in DNA sequencing technologies with the rapid evolution of 
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next-generation sequencing (NGS).  The advent of NGS has significantly increased the 
throughput and reduced sequencing cost by orders of magnitude, making it a cost-
effective option to obtain global genomic information of the same biological system that 
is targeted for proteomics experiments.  
The availability of complete genomics sequences from a species or individual 
facilitates MS-based protein identifications. The DNA sequences from the same system 
can be translated to proteins, resulting in a more accurate protein database for proteomics 
data analysis. An alternative way is to obtain the transcriptome (RNA-Seq) data, which 
may be a better representation for proteins with mutations or splice variants. With the 
cost reduction of NGS in the next few years, it is possible to routinely sequence critical 
samples and use customized protein databases for proteomics data analysis.  
 
V.2.4 Integration of Omics Data 
Proteomics alone may not be sufficient to characterize the complexity of 
biological systems. Recent advances in various omics technologies enable the detection 
of various biological molecules in a high-throughput manner. Combining different omics 
results obtained from the same biological system will substantially increase the 
understanding of complex biological process. Such a success has been demonstrated in 
the field of microbiology (Zhang et al. 2010), plant systems biology (Fukushima et al. 
2009) and mouse organ protein profiling (Kislinger et al. 2006).  
The Cancer Genome Altas (TCGA) initiative has a rich collection of human 
cancer genome data. Recently the NCI CPTAC consortium partnered with TCGA to 
integrate proteomics and genomics data for cancer research. The same tumor specimens 
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studied by the TCGA network will be analyzed by the CPTAC network, generating a pair 
of proteomic and genomic data for each sample. These different types of systematic 
measurements offer insights in how specific gene alterations affect proteins in individual 
tumors. Computational tools to integrate different omics data will play a critical role in 
these studies.  
  
V.2.5 Targeted Proteomics 
While whole proteome analyses have considerable appeal in systems biology, it 
has some practical limits such as relatively low dynamic range. Targeted proteomics, 
especially multiple reaction monitoring (MRM), are emerging to be a promising approach 
that provides greater dynamic range and higher confidence in identifications, which is 
particularly useful for biomarker verification. MRM methods are under active 
development in recent year, requiring the continuous development of bioinformatics tools. 
Algorithms for peptide and transition selection may benefit from mining the vast amount 
of identifications in the spectral libraries. Methods to detect quantification errors and 
estimate the experiment error rate are also desirable. 
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APPENDIX A 
 
SOFTWARE CONFIGURATIONS 
 
MyriMatch Configurations 
 
Thermo Fisher LTQ-XL and LTQ-Velos, Bruker Daltonics HCT Ultra data: 
 
PrecursorMzTolerance= 1.25 
PrecursorMzToleranceUnits = daltons 
FragmentMzTolerance = 0.5 
FragmentMzToleranceUnits = daltons 
AdjustPrecursorMass    = false  
NumSearchBestAdjustments = 3 
DuplicateSpectra = true 
UseChargeStateFromMS = false 
NumChargeStates = 3 
UseSmartPlusThreeModel = false 
TicCutoffPercentage    = 0.95 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages =  2 
NumMinTerminiCleavages =  2 
UseAvgMassOfSequences = true 
MinCandidateLength =  5 
DynamicMods = "M ^ 15.9949 (Q * -17.026" (add [STY] $ 79.9663 for phosphopeptide 
search) 
MaxDynamicMods = 2 
StaticMods = "C 57.0215" 
ComputeXCorr = true 
 
Thermo Fisher LTQ-Orbitrap data: 
 
PrecursorMzTolerance= 10 
PrecursorMzToleranceUnits = ppm 
FragmentMzTolerance = 0.5 
FragmentMzToleranceUnits = daltons 
AdjustPrecursorMass    = true  
MinPrecursorAdjustment = -1.008665  
MaxPrecursorAdjustment = 1.008665  
PrecursorAdjustmentStep = 1.008665  
NumSearchBestAdjustments = 3 
DuplicateSpectra = true 
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UseChargeStateFromMS = true 
NumChargeStates = 4 
UseSmartPlusThreeModel = false 
TicCutoffPercentage    = 0.95 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages =  2 
NumMinTerminiCleavages =  2 
UseAvgMassOfSequences = false 
MinCandidateLength =  5 
DynamicMods = "M ^ 15.9949 (Q * -17.026" (add [STY] $ 79.9663 for phosphopeptide 
search) 
MaxDynamicMods = 2 
StaticMods = "C 57.0215" 
ComputeXCorr = true  
 
AB SCIEX data: 
 
PrecursorMzToleranceRule = “mono” 
AvgPrecursorMzTolerance = 1.5 m/z 
MonoPrecursorMzTolerance = 100 ppm for QSTAR Elite and 50 ppm for TripleTOF 
MonoisotopeAdjustmentSet = [-1,2] 
FragmentMzTolerance = 0.4 m/z for QSTAR Elite and 0.05 m/z for TripleTOF 
StaticMods = "C 57.0215" 
DynamicMods = "M ^ 15.9949 (Q * -17.026" 
MinTerminiCleavages = 1 
CleavageRules = "Trypsin/P" 
MaxMissedCleavages = 2 
MaxDynamicMods = 2 
DecoyPrefix = "rev_" 
NumChargeStates = 3 
OutputFormat= "pepXML" 
SpectrumListFilters = "peakPicking false 2-" 
TicCutoffPercentage = 0.98 
FragmentationAutoRule =  true 
MaxResultRank = 5 
MinPeptideMass = 0 Da 
MaxPeptideMass = 10000 Da 
MinPeptideLength = 5 
MaxPeptideLength = 75 
UseSmartPlusThreeModel = false 
ProteinSampleSize = 100 
ComputeXCorr = true 
UseMultipleProcessors = true 
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Sequest Configurations 
 
“DLD1 LTQ”, “Mouse HCT” and “Yeast Velos” datasets configurations for ScanRanker 
evaluation: 
 
peptide_mass_tolerance = 2.5 
create_output_files = 1 
ion_series = 0 1 1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 
fragment_ion_tolerance = 0.0  
num_output_lines = 5 
num_description_lines = 5 
num_results = 500 
show_fragment_ions = 0 
print_duplicate_references = 1 
enzyme_number = 0 
diff_search_options = 15.9949 M 
term_diff_search_options = 0.000 0.000 
max_num_differential_AA_per_mod = 3 
nucleotide_reading_frame = 0 
mass_type_parent = 0 
mass_type_fragment = 1 
remove_precursor_peak = 0 
ion_cutoff_percentage = 0.0 
protein_mass_filter = 0 0 
max_num_internal_cleavage_sites = 2 
match_peak_count = 0 
match_peak_allowed_error = 1 
match_peak_tolerance = 1.0 
add_C_Cysteine = 57.0215 
 
X!Tandem Configurations 
 
“DLD1 LTQ”, “Mouse HCT” and “Yeast Velos” datasets configurations for ScanRanker 
evaluation: 
 
protein, cleavage semi =  yes 
spectrum, search engine = tandem 
spectrum, minimum cosine theta = 0.3 
output, maximum valid expectation value = 1 
residue, modification mass = 57.0215@C 
residue, potential modification mass = 15.9949@M 
protein, cleavage site = [RK]|{P} 
spectrum, use contrast angle = no 
list path, default parameters = iontrap.xml 
output, xsl path = tandem-style.xsl 
refine = no 
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output, results = all 
 
PepNovo Configurations 
 
model = CID_IT_TRYP 
fragment_tolerance = 0.4 for LTQ-Velos and LTQ-Orbitrap, 0.15 for QSTAR 
pm_tolerance = 2.5 for LTQ-Velos, 0.02 for LTQ-Orbitrap, 0.04 for QSTAR 
no_quality_filter = true 
num_solutions =  10  
PTMs = C+57:M+16  
use_spectrum_charge = false for LTQ-Velos, true for LTQ-Orbitrap and QSTAR 
use_spectrum_mz = false for LTQ-Velos, true for LTQ-Orbitrap and QSTAR 
 
TagRecon Configurations 
 
“Histone Orbi” dataset configurations for ScanRanker evaluation: 
 
PrecursorMzTolerance= 0.01 
FragmentMzTolerance = 0.5 
NTerminusMzTolerance =  0.5 
CTerminusMzTolerance =  0.5 
AdjustPrecursorMass =  false 
MaxPrecursorAdjustment =  1.008665 
MinPrecursorAdjustment =  -1.008665 
PrecursorAdjustmentStep =  1.008665 
NumSearchBestAdjustments = 3 
DuplicateSpectra = true 
UseChargeStateFromMS = true 
NumChargeStates = 3 
UseSmartPlusThreeModel = true 
TicCutoffPercentage = 0.98 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages = 2  
NumMinTerminiCleavages =  1 
UseAvgMassOfSequences = false 
StaticMods = "" 
DynamicMods = "M ^ 15.9949 (Q * -17.026 ( $ 42.015 C @ 57.021 [NQ] % 0.98" 
MaxDynamicMods = 3 
ExplainUnknownMassShiftsAs = "blindptms" 
BlosumThreshold = -4 
UseNETAdjustment = true 
ComputeXCorr = true 
MinCandidateLength =  5 
MaxResults = 5 
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Pepitome Configurations 
 
PrecursorMzToleranceRule = "avg" 
MonoPrecursorMzTolerance = "10 ppm" 
AvgPrecursorMzTolerance = "1.5 mz" 
FragmentMzTolerance = "0.5 mz" 
SpectrumListFilters = "peakPicking true 2-;chargeStatePredictor false 3 2 0.9" 
RecalculateLibPepMasses = false 
CleanLibSpectra = true 
LibTicCuttoffPercentage = 0.98f 
LibMaxPeakCount = 100 
MonoisotopeAdjustmentSet = "0" 
TicCutoffPercentage = 0.98 
MaxPeakCount = 150 
CleavageRules =  "trypsin" 
MaxMissedCleavages =  2 
MinTerminiCleavages =  1 
MinPeptideLength =  5 
DynamicMods = "C % 57.021" 
MaxDynamicMods = 3 
StaticMods = "" 
MaxResultRank = 2 
FASTARefreshResults = false 
 
ScanRanker Configurations 
 
PrecursorMzTolerance = 1.25 for LTQ, 0.1 for LTQ-Orbitrap, 0.25 for QSTAR 
FragmentMzTolerance = 0.5 for LTQ, 0.1 for LTQ-Orbitrap, 0.25 for QSTAR 
IsotopeMzTolerance = 0.25 for LTQ and LTQ-Orbitrap, 0.125 for QSTAR 
StaticMods = C 57.0215 
NumChargeStates = 3 
UseAvgMassOfSequences = 1 for LTQ, 0 for LTQ-Orbitrap and QSTAR 
UseChargeStateFromMS = 0 for LTQ, 1 for LTQ-Orbitrap and QSTAR 
UseMultipleProcessors = 0 
WriteOutTags = 0 
 
IDPicker Configurations 
 
Maximum FDR = 0.05 
Minimum distinct peptides = 2 (1 for synthetic peptide data) 
Minimum additional peptides = 1 
Minimum spectra per protein = 2 (1 for synthetic peptide data) 
 
QuaMeter Configurations 
 
RawDataPath = ../mzMLs/  # where to find the raw files for each idpDB 
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RawDataFormat = mzML     # the file extension to expect for the raw files; e.g. mzML, 
mzXML, raw 
Instrument = LTQ                  # if set to LTQ, average masses are used, else monoisotopic 
masses 
ScoreCutoff = 0.05                # IDPicker FDR cutoff 
ChromatogramMzLoIrOffset = 1.0mz   # the loIr bound of the window for building 
chromatograms; can be in m/z or ppm 
ChromatogramMzUpperOffset = 1.0mz   # the upper bound of the window for building 
chromatograms; can be in m/z or ppm 
ChromatogramOutput = false          # if true, creates an mz5 file with the chromatograms 
(best vieId with SeeMS) 
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